data_2jq4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jq4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.541 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD13 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD2' HD13 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.447 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.406 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.46 ' OD2' ' HB1' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.595 ' HE3' ' HZ ' ' A' ' 63' ' ' PHE . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.477 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HZ ' ' HE3' ' A' ' 42' ' ' MET . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.594 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HA ' HG13 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.497 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD2' HD11 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.501 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HA ' HD13 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.605 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.424 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.465 ' HB3' HD12 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.605 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.564 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.487 HD21 HD23 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.571 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD2' HD11 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG21 ' HB3' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.512 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.481 HG12 HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.452 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.676 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.759 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.5 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.619 ' O ' HG11 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.435 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 12' ' ' PHE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.48 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' A' ' 40' ' ' GLN . 79.5 mm-40 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.501 HG22 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.521 HD12 HD23 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HZ2' ' A' ' 67' ' ' LYS . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.445 ' HG2' HE21 ' A' ' 14' ' ' GLN . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.439 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HZ2' ' HG2' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' HD12 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.615 ' O ' HG21 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD11 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD22 HD21 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.629 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.546 ' O ' HG21 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.432 ' HA ' ' HE2' ' A' ' 42' ' ' MET . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG21 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.444 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HE2' HD12 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.531 HG23 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 5' ' ' ILE . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD22 HD23 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.43 ' HD2' HD11 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.563 ' O ' HG21 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.642 ' HA ' HD22 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HA ' ' HE3' ' A' ' 42' ' ' MET . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' A' ' 39' ' ' VAL . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.537 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.417 ' OD2' HG21 ' A' ' 51' ' ' ILE . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB3' HD13 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB2' ' HZ3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.618 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.618 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.46 HD12 HG21 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' HE1' ' HA ' ' A' ' 74' ' ' LYS . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.403 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.494 HD13 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' HD13 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.436 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' O ' HG21 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.442 ' O ' HG21 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.675 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' HZ ' HG23 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 42' ' ' MET . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' ILE . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.546 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' HG23 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.496 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 67' ' ' LYS . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.505 ' O ' HG22 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.699 ' HA ' HD21 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.506 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' HG21 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.421 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.622 ' HB3' HD12 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.513 ' HA ' HG21 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HZ2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.502 HD22 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.581 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HD2' HD13 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.436 HG22 ' HB1' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.553 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.431 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 33' ' ' LEU . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.637 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' HE1' ' A' ' 42' ' ' MET . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' A' ' 39' ' ' VAL . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.515 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.419 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 19' ' ' VAL . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.486 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.597 ' O ' HG21 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 10' ' ' ALA . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.597 HG21 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.479 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 22' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.545 ' HA ' HD22 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.404 ' OD2' HG21 ' A' ' 51' ' ' ILE . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.495 ' HA ' HG23 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.492 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG21 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.564 ' HB3' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.431 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.589 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HZ2' ' A' ' 67' ' ' LYS . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.448 HD21 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.656 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.564 HE22 ' HB3' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.404 ' H ' HD11 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.534 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.433 ' HA ' HG21 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.573 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.8 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 3.5 p-10 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.671 ' O ' HG21 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.671 HG21 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.555 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.699 HD13 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.404 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.699 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HB1' HG22 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HA ' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.525 ' OD2' HG22 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.525 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.479 ' HA ' HD11 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.599 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HZ1' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.547 HD22 HD23 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.604 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.57 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' HG21 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.635 ' HA ' HD22 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.604 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.522 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CE2' HG22 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' OD2' HG22 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.848 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB3' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.515 HG13 HD12 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' N ' HD11 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 5' ' ' ILE . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HG21 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.635 HG21 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.651 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.569 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD2' HD13 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.505 HG11 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.541 HD13 HD11 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' O ' HD21 ' A' ' 28' ' ' LEU . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.541 HD11 HD13 ' A' ' 22' ' ' ILE . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.496 ' O ' ' HG2' ' A' ' 42' ' ' MET . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.707 ' HB3' HD12 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.584 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.57 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.511 HG21 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB2' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' HD21 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.671 HD12 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.461 HD22 HD23 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 16' ' ' PRO . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 HD13 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.599 HG21 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.535 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 29' ' ' TYR . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD22 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.727 ' HE1' ' HD2' ' A' ' 53' ' ' PHE . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE2' HG22 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HD2' ' HE1' ' A' ' 42' ' ' MET . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' HG23 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.511 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.611 HD13 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.611 ' HE2' HD13 ' A' ' 41' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' HG12 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.601 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.503 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.526 HG21 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.818 ' HB3' HD13 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.818 HD13 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.525 ' HA ' HG23 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG23 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HA ' HG13 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.473 ' HE2' HG12 ' A' ' 73' ' ' VAL . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.433 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.431 HE21 ' HG2' ' A' ' 40' ' ' GLN . 73.3 mm-40 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.479 HD11 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD2' HD11 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.414 HD13 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.489 ' HA ' HD21 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.407 ' O ' HD21 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.547 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.502 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.765 ' HB3' HD13 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.473 HG12 ' HE2' ' A' ' 1' ' ' MET . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.623 ' O ' HG21 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.623 HG21 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.54 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HD2' HD11 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG21 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.547 HD13 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD22 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 42' ' ' MET . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.562 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' HD23 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.402 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.512 HG22 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.553 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.449 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.553 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD13 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.492 ' HD2' HD13 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.447 HG22 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.406 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.481 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.46 ' OD2' ' HB1' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.46 ' HB1' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.45 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.595 ' HE3' ' HZ ' ' A' ' 63' ' ' PHE . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.477 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' OD2' HG22 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.477 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.659 ' HB3' HD12 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.595 ' HZ ' ' HE3' ' A' ' 42' ' ' MET . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.594 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.496 ' HA ' HG21 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.594 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.496 HG21 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.52 ' HA ' HG13 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.582 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.52 HG13 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.482 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.98 54.32 0.38 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.458 ' HG2' HG23 ' A' ' 76' ' ' ILE . 50.7 mtmt -52.19 -56.35 15.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.272 0.558 . . . . 0.0 111.432 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -69.28 -8.66 48.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.609 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.41 0.34 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.455 178.623 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.622 ' O ' HG23 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.622 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.58 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.552 HD11 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.552 ' HD2' HD11 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.512 HG22 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.501 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.521 ' HA ' HD13 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.605 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' HB2' HG22 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.444 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.478 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE2' HG21 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.424 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 HG13 HG23 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.465 ' HB3' HD12 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.431 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.521 HD13 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.605 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.498 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.1 45.52 1.3 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.514 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 8.0 mmpt? -55.5 -46.26 76.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.713 0.768 . . . . 0.0 110.195 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.32 -13.59 20.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.826 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.84 -23.91 12.96 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 111.105 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.591 -178.229 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.564 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.571 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.487 HD21 HD23 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.571 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.547 HD11 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.547 ' HD2' HD11 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.465 HG21 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG21 ' HB3' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.443 HD13 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.512 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.502 ' O ' HD12 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.481 HG12 HG23 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.449 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.452 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.463 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.676 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.759 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.583 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.583 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.5 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.619 ' O ' HG11 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.439 ' N ' HD13 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.518 HD11 ' HG3' ' A' ' 80' ' ' LYS . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -122.22 45.22 1.23 Allowed Glycine 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.518 ' HG3' HD11 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -71.05 -48.26 53.81 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.218 0.607 . . . . 0.0 111.533 -174.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.0 -47.14 72.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.83 74.18 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.184 -178.962 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.435 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.435 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG12 ' HB2' ' A' ' 12' ' ' PHE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.48 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.445 HE21 ' HG2' ' A' ' 40' ' ' GLN . 79.5 mm-40 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 HD13 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.501 HG22 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG23 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.521 HD12 HD23 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.513 ' HG2' ' HZ2' ' A' ' 67' ' ' LYS . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 HD23 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.456 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.431 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.456 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.445 ' HG2' HE21 ' A' ' 14' ' ' GLN . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.48 HD13 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.439 ' OD2' HG22 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.439 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.645 ' HB3' HD12 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.645 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.4 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.551 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HZ2' ' HG2' ' A' ' 25' ' ' GLU . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.446 HG23 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.419 HG22 HD13 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.529 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.63 -21.94 74.96 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.43 ' NZ ' ' OD2' ' A' ' 50' ' ' ASP . 75.0 mttt -61.17 -43.07 99.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.255 176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -79.13 -45.75 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.072 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.78 77.14 2.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.669 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.687 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' SD ' HD12 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.615 ' O ' HG21 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD11 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.538 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.629 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD22 HD21 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.538 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.629 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.443 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.546 ' O ' HG21 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.427 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.546 HG21 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.478 HG22 ' HB3' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.508 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB3' HG22 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.508 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.432 ' HA ' ' HE2' ' A' ' 42' ' ' MET . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.449 HD12 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.442 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 HG22 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG21 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.444 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HE2' HD12 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.504 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.648 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.473 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.531 HG23 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.544 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.78 81.04 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.3 mmmt -75.16 -51.54 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 59.18 32.48 22.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.673 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.95 72.26 3.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.004 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.675 -176.78 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' HG13 ' A' ' 5' ' ' ILE . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.577 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD22 HD23 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.577 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD11 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.43 ' HD2' HD11 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.563 ' O ' HG21 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.483 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.563 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.478 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.478 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.439 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.642 ' HA ' HD22 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 ' HA ' ' HE3' ' A' ' 42' ' ' MET . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.554 ' HE3' ' HA ' ' A' ' 39' ' ' VAL . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.537 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.583 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.537 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.583 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.628 ' HB3' HD13 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.55 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.652 ' HB2' ' HZ3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.618 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.618 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.46 HD12 HG21 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.31 24.0 34.02 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.455 ' HZ3' ' CG ' ' A' ' 50' ' ' ASP . 40.4 mtmt -71.52 -58.83 3.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 117.128 0.464 . . . . 0.0 111.46 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 64.17 87.52 0.11 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.279 -170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.63 94.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.398 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.447 -177.542 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HE1' ' HA ' ' A' ' 74' ' ' LYS . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.481 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.408 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.403 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.494 HD13 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' HD13 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' O ' HG21 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.539 HG21 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.484 HD12 HD21 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.427 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.549 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.484 HD21 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.442 ' O ' HG21 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.675 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.442 HG21 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.505 ' CE2' HG22 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' HZ ' HG23 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.423 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.493 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.492 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.416 ' CZ ' ' HE3' ' A' ' 42' ' ' MET . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.462 ' HA ' HG21 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.549 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.462 HG21 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.436 HG13 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.536 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.7 46.22 1.2 Allowed Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -43.86 -66.82 0.34 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.231 0.613 . . . . 0.0 112.319 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.51 33.56 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.613 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.03 5.72 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.706 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.737 -177.383 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' O ' HG13 ' A' ' 5' ' ' ILE . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.642 ' O ' HG23 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.642 HG23 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.546 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' HG23 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.496 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 67' ' ' LYS . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.525 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.505 ' O ' HG22 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.699 ' HA ' HD21 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.699 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.506 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' OD2' HG21 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.421 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.622 ' HB3' HD12 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.622 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.513 ' HA ' HG21 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.49 ' HZ2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.486 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.477 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.12 69.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' A' ' 77' ' ' LEU . 2.8 mppt? -61.16 -50.45 73.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.922 0.392 . . . . 0.0 110.054 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.43 14.92 6.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.732 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.9 72.45 7.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.924 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.041 -177.515 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.585 ' O ' HG23 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.596 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.585 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.502 HD22 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.596 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.581 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.536 HD13 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.536 ' HD2' HD13 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.406 HG22 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.601 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.436 HG22 ' HB1' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.548 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.553 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.431 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' HB3' HD11 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB1' HG22 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.409 ' HB3' HD21 ' A' ' 33' ' ' LEU . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.637 ' HA ' HD21 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' HE1' ' A' ' 42' ' ' MET . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.413 ' HE1' ' HA ' ' A' ' 39' ' ' VAL . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.515 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.515 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.416 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.416 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.565 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.565 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.515 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.413 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.548 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.553 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.49 59.99 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 77' ' ' LEU . 26.1 mmmt -51.07 -64.45 0.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.36 -7.14 22.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.054 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.93 84.5 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.139 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.65 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.566 ' O ' HG23 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.419 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HA ' HG22 ' A' ' 19' ' ' VAL . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.486 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.531 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.597 ' O ' HG21 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 HG22 ' HA ' ' A' ' 10' ' ' ALA . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.597 HG21 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.552 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.479 HD22 HD12 ' A' ' 22' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.51 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.545 ' HA ' HD22 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.571 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.571 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.409 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 HG21 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD13 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.41 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.617 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.41 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.495 ' HA ' HG23 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.552 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.495 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG21 HD13 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.49 HD13 HG21 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.16 -49.08 2.7 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.414 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 23.2 mmmt 58.93 -76.85 0.02 OUTLIER 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.22 1.008 . . . . 0.0 111.727 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.06 14.87 0.4 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.528 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.64 93.56 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.895 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.099 178.947 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HE3' ' HA ' ' A' ' 74' ' ' LYS . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG21 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.402 ' HB3' HD11 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG21 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.564 ' HB3' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.497 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.431 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.589 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.589 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.455 HG22 ' HB3' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HZ2' ' A' ' 67' ' ' LYS . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.448 HD21 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.467 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.656 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.564 HE22 ' HB3' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.515 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.41 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG12 HG22 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CE2' HG22 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.404 ' H ' HD11 ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.511 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.538 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.534 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.433 ' HA ' HG21 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.534 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.433 HG21 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.573 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.617 ' HZ3' ' HB2' ' A' ' 74' ' ' LYS . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.476 HD12 HG21 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.34 69.86 0.25 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 77' ' ' LEU . 9.2 mptt -56.49 -47.54 79.06 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -177.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -90.59 -26.33 19.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.473 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.92 79.63 4.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.081 179.367 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.8 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 3.5 p-10 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.671 ' O ' HG21 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.537 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.671 HG21 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.555 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.404 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.56 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.524 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.524 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.521 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.521 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.699 HD13 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.404 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.631 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.404 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.699 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.515 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HB1' HG22 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.41 ' O ' HG21 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.41 HG21 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.49 ' HA ' HD11 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.455 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.549 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.502 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.525 ' OD2' HG22 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.525 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.455 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.587 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.479 ' HA ' HD11 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.479 HD11 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.434 ' HA ' HG21 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.631 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.434 HG21 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.8 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.599 ' HA ' ' HZ1' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.599 ' HZ1' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.497 HD12 HG21 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.79 37.37 3.74 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -42.82 -65.17 0.51 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.902 0.481 . . . . 0.0 111.692 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.53 26.94 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.477 0.656 . . . . 0.0 109.536 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.67 12.86 11.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.72 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.044 178.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.602 ' O ' HG23 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.602 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.547 HD22 HD23 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.536 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.604 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.57 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.57 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.406 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD12 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' HG23 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' HG21 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.635 ' HA ' HD22 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.604 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.635 HD22 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.522 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG22 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' CE2' HG22 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' OD2' HG22 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.425 HG22 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.848 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.848 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.487 ' HB3' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.515 HG13 HD12 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.413 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.604 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' N ' HD11 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.7 57.88 0.17 Allowed Glycine 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 2.7 mppt? -45.35 -68.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.29 0.567 . . . . 0.0 111.905 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -12.94 18.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.32 80.69 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.487 -178.327 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' O ' HG13 ' A' ' 5' ' ' ILE . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.635 ' O ' HG21 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.635 HG21 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.651 ' HB2' ' HZ2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.569 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 HD13 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.514 ' HD2' HD13 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.505 HG11 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.541 HD13 HD11 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.562 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' O ' HD21 ' A' ' 28' ' ' LEU . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.541 HD11 HD13 ' A' ' 22' ' ' ILE . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.496 ' O ' ' HG2' ' A' ' 42' ' ' MET . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.511 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.511 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.707 ' HB3' HD12 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.507 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.584 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG21 HD13 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.584 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.511 HD13 HG21 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.67 65.78 0.39 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.517 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 6.2 mmpt? -65.09 -64.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.073 0.463 . . . . 0.0 110.725 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.29 -31.2 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.403 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.42 82.16 8.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.452 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.282 -177.827 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.565 ' O ' HG23 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.57 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.5 HD13 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' HD13 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.511 HG21 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.56 ' O ' HG21 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB2' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.444 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.425 ' HB2' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD11 HD13 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.463 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.463 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.599 ' HA ' HD21 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.599 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.549 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.549 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.88 71.32 0.28 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.423 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 3.2 mppt? -58.69 -42.39 88.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.47 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.57 55.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.63 21.11 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.237 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.448 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.671 HD12 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.461 HD22 HD23 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' A' ' 16' ' ' PRO . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 HG11 HD13 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.599 HG21 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.493 HG21 ' HB3' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' O ' HD23 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.525 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.493 ' HB3' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' A' ' 29' ' ' TYR . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD22 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.708 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.727 ' HE1' ' HD2' ' A' ' 53' ' ' PHE . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.51 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.51 HD11 ' HA ' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' CE2' HG22 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.487 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.727 ' HD2' ' HE1' ' A' ' 42' ' ' MET . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.443 ' HA ' HG23 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' HA ' HG13 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.489 HG13 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.457 HD11 HG22 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.505 ' O ' ' HB1' ' A' ' 83' ' ' ALA . . . -103.36 46.93 1.15 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 39.8 mtmt -91.22 -63.53 1.25 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.393 0.616 . . . . 0.0 111.265 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.72 -14.59 63.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.701 -169.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.39 14.83 20.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.838 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' O ' HG21 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.535 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.554 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.406 ' O ' HG21 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.406 HG21 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.511 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.611 HD13 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.515 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 45' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.611 ' HE2' HD13 ' A' ' 41' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.608 HD12 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.528 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.528 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.553 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.518 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.518 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD22 ' HD3' ' A' ' 80' ' ' LYS . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.27 71.25 0.43 Allowed Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' HD3' HD22 ' A' ' 77' ' ' LEU . 12.0 mmmm -59.88 -70.35 0.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.06 0.457 . . . . 0.0 111.239 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 34.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.315 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.07 41.34 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.496 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 -177.574 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' HG12 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG23 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.601 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.503 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.503 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.446 HD13 HD21 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.561 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD11 HD13 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.53 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.482 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.527 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.526 HG21 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.526 ' CE2' HG21 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.447 ' OD2' HG22 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.509 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.818 ' HB3' HD13 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.4 ' HA ' HD13 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.818 HD13 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.525 ' HA ' HG23 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG23 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.436 ' HA ' HG13 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.516 HG12 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.502 HD12 HG21 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.88 68.05 0.4 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 38.9 mtmt -81.96 -45.37 15.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.193 0.521 . . . . 0.0 110.628 177.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.34 21.98 2.88 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.57 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.6 80.44 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.828 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.516 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HE2' HG12 ' A' ' 73' ' ' VAL . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.586 ' O ' HG23 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.433 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.431 HE21 ' HG2' ' A' ' 40' ' ' GLN . 73.3 mm-40 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.479 HD11 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD2' HD11 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.498 HG22 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 HD13 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.528 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.507 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB3' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.453 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.453 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.489 ' HA ' HD21 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.407 ' O ' HD21 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.527 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.547 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.407 HD21 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.438 ' HA3' HD12 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.502 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.506 ' OD1' HG22 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.506 HG22 ' OD1' ' A' ' 50' ' ' ASP . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.765 ' HB3' HD13 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD2' HD22 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.765 HD13 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.458 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.528 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.494 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.473 HG12 ' HE2' ' A' ' 1' ' ' MET . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.51 62.21 0.35 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.447 ' HZ2' ' CG ' ' A' ' 50' ' ' ASP . 41.7 mtmt -64.99 -71.54 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.601 177.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 59.73 16.57 5.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.479 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 103.55 14.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.558 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.325 -179.211 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.52 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.623 ' O ' HG21 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.623 HG21 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.54 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 HD11 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HD2' HD11 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG21 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.557 HG21 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.547 HD13 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' H ' ' HB1' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.525 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.413 ' HB1' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.547 ' HG ' HD13 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG12 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.758 ' HA ' HD22 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.47 ' HA ' ' HE3' ' A' ' 42' ' ' MET . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.562 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.42 HG22 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CE2' HG22 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.512 HG13 HG22 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' HD2' HD23 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.562 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG23 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG23 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.402 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.512 HG22 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.48 28.66 11.98 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.8 mmmt -74.42 -66.81 0.69 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 56.46 81.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.282 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.76 97.32 3.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.97 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.495 -177.897 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG22 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 38' ' ' SER . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.541 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB3' HD11 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 63' ' ' PHE . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HE2' ' HA ' ' A' ' 58' ' ' LEU . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' HG23 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB3' HD11 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.585 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.597 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.497 HG23 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' HG22 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 22' ' ' ILE . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.655 HD12 HD22 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.563 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.607 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.507 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD2' HG23 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD11 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG23 HD12 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.655 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 69.9 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.561 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.523 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 35' ' ' SER . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' HE2' HD11 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 69' ' ' ILE . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 73' ' ' VAL . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.614 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.674 ' HA ' HD23 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.674 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.551 ' SD ' HD22 ' A' ' 58' ' ' LEU . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.56 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.584 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.627 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.627 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.599 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.567 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.539 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.733 ' HA ' HD23 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' HD11 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.525 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.532 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' ARG . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.486 HG23 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 22' ' ' ILE . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 66' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.569 ' HA ' HD23 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 51' ' ' ILE . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB3' HD11 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 5' ' ' ILE . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.647 ' O ' HG22 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.603 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.769 ' HD2' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.702 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.769 HE22 ' HD2' ' A' ' 12' ' ' PHE . 18.5 tm0? -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.519 HG12 HG21 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.549 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 8.0 p30 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.636 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.547 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 61' ' ' LYS . 31.7 p-10 -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HB3' ' ND2' ' A' ' 59' ' ' ASN . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.807 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 12' ' ' PHE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.621 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.457 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HA ' HG22 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 60' ' ' ARG . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.537 HG13 HD11 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 66' ' ' ILE . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.607 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.524 ' HA ' HD23 ' A' ' 41' ' ' LEU . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.604 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 21' ' ' THR . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' HB3' HD11 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HA ' HD12 ' A' ' 76' ' ' ILE . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 73' ' ' VAL . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.663 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.565 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HD23 ' A' ' 33' ' ' LEU . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 15' ' ' LEU . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.743 ' HA ' HD23 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.421 ' HE2' ' HG ' ' A' ' 41' ' ' LEU . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG12 HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.663 ' HZ ' HD13 ' A' ' 5' ' ' ILE . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.426 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' HG22 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.611 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.635 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' MET . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.615 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' SER . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 8' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD11 ' A' ' 57' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' HG13 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.605 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD2' HG23 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB3' HD11 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.847 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.536 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.527 HG13 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 70' ' ' GLU . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 49' ' ' PHE . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.512 HG23 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.446 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HD23 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' HD21 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.58 HD12 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.577 ' O ' HG22 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.566 HD12 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.552 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.782 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 35' ' ' SER . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.564 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.435 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD2' HG23 ' A' ' 51' ' ' ILE . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' HD21 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.577 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.405 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG22 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 38' ' ' SER . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB3' HD11 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 63' ' ' PHE . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HE2' ' HA ' ' A' ' 58' ' ' LEU . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.98 54.32 0.38 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 76' ' ' ILE . 50.7 mtmt -52.19 -56.35 15.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.272 0.558 . . . . 0.0 111.432 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -69.28 -8.66 48.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.609 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.41 0.34 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.455 178.623 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' HG23 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB3' HD11 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.1 45.52 1.3 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 8.0 mmpt? -55.5 -46.26 76.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.713 0.768 . . . . 0.0 110.195 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.32 -13.59 20.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.826 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.84 -23.91 12.96 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 111.105 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.591 -178.229 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.585 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.597 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD13 ' HG3' ' A' ' 80' ' ' LYS . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -122.22 45.22 1.23 Allowed Glycine 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -71.05 -48.26 53.81 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.218 0.607 . . . . 0.0 111.533 -174.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.0 -47.14 72.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.83 74.18 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.184 -178.962 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.497 HG23 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' HG22 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 22' ' ' ILE . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.655 HD12 HD22 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.563 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.607 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.507 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD2' HG23 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD11 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG23 HD12 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.63 -21.94 74.96 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -61.17 -43.07 99.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.255 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -79.13 -45.75 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.072 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.78 77.14 2.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.669 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.687 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.655 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 69.9 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.561 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.523 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 35' ' ' SER . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' HE2' HD11 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 69' ' ' ILE . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 73' ' ' VAL . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.78 81.04 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.3 mmmt -75.16 -51.54 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 59.18 32.48 22.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.673 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.95 72.26 3.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.004 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.675 -176.78 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.614 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.674 ' HA ' HD23 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.674 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.551 ' SD ' HD22 ' A' ' 58' ' ' LEU . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.56 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.584 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.627 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.627 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.31 24.0 34.02 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 77' ' ' LEU . 40.4 mtmt -71.52 -58.83 3.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 117.128 0.464 . . . . 0.0 111.46 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 64.17 87.52 0.11 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.279 -170.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.63 94.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.398 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.447 -177.542 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.599 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.567 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD13 ' HD3' ' A' ' 80' ' ' LYS . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.7 46.22 1.2 Allowed Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HD3' HD13 ' A' ' 77' ' ' LEU . 27.7 mmmt -43.86 -66.82 0.34 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.231 0.613 . . . . 0.0 112.319 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.51 33.56 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.613 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.03 5.72 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.706 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.737 -177.383 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.733 ' HA ' HD23 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' HD11 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.12 69.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 77' ' ' LEU . 2.8 mppt? -61.16 -50.45 73.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.922 0.392 . . . . 0.0 110.054 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.43 14.92 6.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.732 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.9 72.45 7.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.924 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.041 -177.515 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.9 tm0? -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.525 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.532 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.49 59.99 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 77' ' ' LEU . 26.1 mmmt -51.07 -64.45 0.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.36 -7.14 22.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.054 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.93 84.5 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.139 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.65 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' ARG . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.486 HG23 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 22' ' ' ILE . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 66' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.569 ' HA ' HD23 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 51' ' ' ILE . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB3' HD11 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD13 ' HD3' ' A' ' 80' ' ' LYS . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.16 -49.08 2.7 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' HD13 ' A' ' 77' ' ' LEU . 23.2 mmmt 58.93 -76.85 0.02 OUTLIER 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.22 1.008 . . . . 0.0 111.727 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.06 14.87 0.4 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.528 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.64 93.56 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.895 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.099 178.947 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 5' ' ' ILE . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.647 ' O ' HG22 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.769 ' HD2' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.702 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.769 HE22 ' HD2' ' A' ' 12' ' ' PHE . 18.5 tm0? -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.519 HG12 HG21 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.549 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.34 69.86 0.25 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 9.2 mptt -56.49 -47.54 79.06 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -177.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -90.59 -26.33 19.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.473 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.92 79.63 4.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.081 179.367 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 8.0 p30 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.636 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.547 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.419 ' ND2' ' HB3' ' A' ' 61' ' ' LYS . 31.7 p-10 -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HB3' ' ND2' ' A' ' 59' ' ' ASN . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.807 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.79 37.37 3.74 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -42.82 -65.17 0.51 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.902 0.481 . . . . 0.0 111.692 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.53 26.94 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.477 0.656 . . . . 0.0 109.536 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.67 12.86 11.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.72 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.044 178.059 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 12' ' ' PHE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.621 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.457 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HA ' HG22 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 60' ' ' ARG . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.537 HG13 HD11 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 66' ' ' ILE . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.607 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.7 57.88 0.17 Allowed Glycine 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 2.7 mppt? -45.35 -68.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.29 0.567 . . . . 0.0 111.905 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -12.94 18.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.32 80.69 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.487 -178.327 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.524 ' HA ' HD23 ' A' ' 41' ' ' LEU . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.604 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.67 65.78 0.39 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 6.2 mmpt? -65.09 -64.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.073 0.463 . . . . 0.0 110.725 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.29 -31.2 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.403 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.42 82.16 8.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.452 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.282 -177.827 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 21' ' ' THR . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' HB3' HD11 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HA ' HD12 ' A' ' 76' ' ' ILE . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 73' ' ' VAL . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.88 71.32 0.28 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 3.2 mppt? -58.69 -42.39 88.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.47 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.57 55.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.63 21.11 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.237 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.663 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.565 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HD23 ' A' ' 33' ' ' LEU . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 15' ' ' LEU . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.743 ' HA ' HD23 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.421 ' HE2' ' HG ' ' A' ' 41' ' ' LEU . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG12 HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.663 ' HZ ' HD13 ' A' ' 5' ' ' ILE . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.426 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' HG22 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -103.36 46.93 1.15 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 77' ' ' LEU . 39.8 mtmt -91.22 -63.53 1.25 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.393 0.616 . . . . 0.0 111.265 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.72 -14.59 63.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.701 -169.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.39 14.83 20.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.838 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.611 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.635 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' MET . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.615 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' SER . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 8' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD11 ' A' ' 57' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.529 HD23 ' HD3' ' A' ' 80' ' ' LYS . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.27 71.25 0.43 Allowed Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HD3' HD23 ' A' ' 77' ' ' LEU . 12.0 mmmm -59.88 -70.35 0.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.06 0.457 . . . . 0.0 111.239 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 34.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.315 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.07 41.34 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.496 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 -177.574 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' HG13 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.605 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD2' HG23 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB3' HD11 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.847 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.536 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.527 HG13 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 70' ' ' GLU . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.88 68.05 0.4 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -81.96 -45.37 15.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.193 0.521 . . . . 0.0 110.628 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.34 21.98 2.88 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.57 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.6 80.44 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.828 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.516 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 49' ' ' PHE . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.512 HG23 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HD23 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' HD21 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.51 62.21 0.35 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -64.99 -71.54 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.601 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 59.73 16.57 5.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.479 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 103.55 14.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.558 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.325 -179.211 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.58 HD12 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.577 ' O ' HG22 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.566 HD12 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.552 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.782 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 35' ' ' SER . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.564 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.435 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD2' HG23 ' A' ' 51' ' ' ILE . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' HD21 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.577 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.405 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.48 28.66 11.98 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.8 mmmt -74.42 -66.81 0.69 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 56.46 81.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.282 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.76 97.32 3.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.97 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.495 -177.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.433 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG22 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 38' ' ' SER . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.541 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB3' HD11 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 63' ' ' PHE . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HE2' ' HA ' ' A' ' 58' ' ' LEU . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' HG23 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB3' HD11 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.585 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.597 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HG2' ' A' ' 40' ' ' GLN . 79.5 mm-40 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.497 HG23 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' HG22 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 22' ' ' ILE . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.655 HD12 HD22 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.438 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.563 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.607 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.48 ' HG2' HE21 ' A' ' 14' ' ' GLN . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.507 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD2' HG23 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD11 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.43 HG23 HD12 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.655 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 18.2 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.561 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.523 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 35' ' ' SER . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' HE2' HD11 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 69' ' ' ILE . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 73' ' ' VAL . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.582 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.614 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.674 ' HA ' HD23 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.674 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.551 ' SD ' HD22 ' A' ' 58' ' ' LEU . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.56 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.584 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.627 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.627 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.599 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.567 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.539 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.733 ' HA ' HD23 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' HD11 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.525 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.532 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.532 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.425 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' ARG . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.486 HG23 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 22' ' ' ILE . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 66' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.569 ' HA ' HD23 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 51' ' ' ILE . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB3' HD11 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 5' ' ' ILE . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.647 ' O ' HG22 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.603 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.619 ' HB3' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.702 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.619 HE22 ' HB3' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.519 HG12 HG21 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.549 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 3.5 p-10 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.636 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.547 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.807 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.557 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 12' ' ' PHE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.621 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.457 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HA ' HG22 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 60' ' ' ARG . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.537 HG13 HD11 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 66' ' ' ILE . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.607 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.524 ' HA ' HD23 ' A' ' 41' ' ' LEU . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.604 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 21' ' ' THR . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' HB3' HD11 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HA ' HD12 ' A' ' 76' ' ' ILE . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 73' ' ' VAL . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.663 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.565 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HD23 ' A' ' 33' ' ' LEU . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.527 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 15' ' ' LEU . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.743 ' HA ' HD23 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.421 ' HE2' ' HG ' ' A' ' 41' ' ' LEU . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.534 HG12 HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.663 ' HZ ' HD13 ' A' ' 5' ' ' ILE . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.426 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' HG22 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.611 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.635 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.402 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' MET . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.615 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' SER . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 8' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD11 ' A' ' 57' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' HG13 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.605 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD2' HG23 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB3' HD11 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.847 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.536 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.527 HG13 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 70' ' ' GLU . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 49' ' ' PHE . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.488 HE21 ' HG2' ' A' ' 40' ' ' GLN . 73.3 mm-40 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.512 HG23 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.446 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HD23 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' HD21 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.58 HD12 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.577 ' O ' HG22 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.566 HD12 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.552 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.782 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 35' ' ' SER . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.564 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.435 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD2' HG23 ' A' ' 51' ' ' ILE . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' HD21 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.577 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.405 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' ILE . 33.6 mtp . . . . . 0 N--CA 1.485 1.306 0 N-CA-C 111.429 0.159 . . . . 0.0 111.429 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -57.8 -45.72 85.67 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -172.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 6' ' ' ARG . . . -68.12 -37.17 80.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.263 0.554 . . . . 0.0 110.033 178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.2 m -62.65 -40.2 96.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.988 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 8' ' ' ILE . 93.5 mt -61.79 -45.72 98.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.287 -177.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.451 ' HG3' ' O ' ' A' ' 3' ' ' ALA . 0.6 OUTLIER -74.71 -27.89 60.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.885 0.374 . . . . 0.0 110.149 178.323 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -67.21 -41.73 85.29 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.764 -177.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 12' ' ' PHE . 6.7 tt -56.81 -32.16 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 111.625 0.231 . . . . 0.0 111.625 -174.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -53.16 -25.83 14.94 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 120.741 0.305 . . . . 0.0 110.911 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.05 76.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.54 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 19.3 ptmt -102.12 -33.22 9.76 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.566 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.6 m-85 -112.08 -36.77 5.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.58 0.228 . . . . 0.0 111.538 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -71.4 128.06 15.16 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.759 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.433 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 58.4 tp60 -77.67 65.16 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.397 0.618 . . . . 0.0 109.865 175.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.7 tp -94.98 124.34 54.61 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.533 ' HD2' HD12 ' A' ' 15' ' ' LEU . 86.7 Cg_endo -79.64 20.21 0.9 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.928 2.418 . . . . 0.0 112.101 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.3 m -150.62 139.85 13.37 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.466 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' O ' HG22 ' A' ' 21' ' ' THR . 23.5 Cg_endo -61.89 131.24 34.17 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.517 2.144 . . . . 0.0 112.034 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.321 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.31 -34.04 55.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.895 177.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 18' ' ' PRO . 9.8 t -81.21 -20.05 41.94 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -174.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 HD12 ' HG ' ' A' ' 28' ' ' LEU . 30.6 pt -105.71 164.67 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.173 0.511 . . . . 0.0 111.286 -177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.498 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.33 -178.61 7.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.228 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.503 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 19.4 p-10 -71.87 -26.29 62.29 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.088 0.47 . . . . 0.0 110.823 -178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -91.75 7.1 43.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.265 177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.498 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.43 154.6 30.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.692 -0.231 . . . . 0.0 110.759 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 9.9 p-10 -86.64 106.59 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.338 0.59 . . . . 0.0 110.023 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.0 mp -60.35 -28.15 67.94 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.527 -0.76 . . . . 0.0 112.231 -173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 37.1 p90 -65.89 -20.74 66.33 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.982 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.448 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -66.11 -27.7 68.25 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.903 0.383 . . . . 0.0 110.742 174.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.59 -9.36 59.43 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.848 178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.37 29.06 5.53 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.281 178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.8 tp -62.29 110.76 1.74 Allowed 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.6 p -102.28 164.34 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.066 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.4 t -60.31 -26.05 66.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.103 0.477 . . . . 0.0 109.738 177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -67.61 -45.04 76.57 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.894 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -66.2 -39.55 89.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.96 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 42' ' ' MET . 19.2 p -71.1 -37.23 72.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.647 -176.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.6 p -69.29 -37.59 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 C-N-CA 120.556 -0.458 . . . . 0.0 110.761 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -64.96 -36.73 85.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.452 0.644 . . . . 0.0 109.404 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.478 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.2 OUTLIER -54.86 -44.54 74.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.316 174.342 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.492 ' HG2' ' O ' ' A' ' 38' ' ' SER . 19.1 mmt -59.28 -55.85 29.55 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.296 0.569 . . . . 0.0 110.61 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.1 mt -53.87 -45.27 70.94 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.535 -173.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.504 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.38 -39.5 22.25 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.679 -177.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.541 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -65.57 -30.12 49.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 O-C-N 122.788 -0.243 . . . . 0.0 111.173 -176.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.474 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 38.6 tt0 -58.67 -56.25 24.54 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.964 0.411 . . . . 0.0 110.112 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.32 -29.75 68.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.422 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.75 -49.89 71.89 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.293 -176.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.541 ' CE2' HG23 ' A' ' 45' ' ' ILE . 44.0 p90 -128.62 -33.95 2.03 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 51' ' ' ILE . 37.5 t70 -179.36 -73.97 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.381 0.511 . . . . 0.0 112.381 -176.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -129.24 169.59 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.038 0.446 . . . . 0.0 111.588 -176.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.13 169.29 8.53 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.775 177.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.713 ' HB3' HD11 ' A' ' 57' ' ' LEU . 57.0 m-85 -68.83 120.68 77.62 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.204 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.82 159.0 42.5 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.812 2.342 . . . . 0.0 112.546 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -53.05 -36.13 60.25 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.827 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -52.03 -32.24 33.37 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.786 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.713 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -115.74 -7.12 12.12 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.602 0.239 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.408 ' HA ' ' HE2' ' A' ' 63' ' ' PHE . 2.9 tt -66.65 -62.68 1.33 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -80.93 74.11 7.94 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 28.1 tpt180 -162.49 163.23 27.6 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.419 -173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -62.93 -8.85 7.93 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.218 0.607 . . . . 0.0 112.477 178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.8 m -47.31 -47.26 25.54 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -174.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.408 ' HE2' ' HA ' ' A' ' 58' ' ' LEU . 87.6 m-85 -63.46 -14.98 56.26 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 -176.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -75.18 -8.68 57.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.957 0.408 . . . . 0.0 110.989 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.578 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 15.6 m -155.26 103.76 2.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.53 ' HA ' HG22 ' A' ' 69' ' ' ILE . 38.0 mm -56.45 -45.8 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.955 -176.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.58 -27.58 64.75 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.784 0.326 . . . . 0.0 111.144 -178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.03 -48.41 16.21 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 110.572 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.4 tt -68.86 -32.28 54.06 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.107 -177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.8 OUTLIER -65.33 -34.5 78.48 Favored 'General case' 0 C--O 1.228 -0.054 0 CA-C-O 120.798 0.332 . . . . 0.0 110.427 -177.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -66.63 -37.3 84.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.217 0.532 . . . . 0.0 109.731 176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.586 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 16.8 m -70.7 -33.05 70.48 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.261 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.531 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.3 p -75.96 -29.03 19.43 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.877 -0.514 . . . . 0.0 110.117 174.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 58.8 mtpt -63.53 -41.04 98.49 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.536 177.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -63.84 -28.62 69.98 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.431 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.48 HD12 HG23 ' A' ' 73' ' ' VAL . 69.1 mt -55.58 -52.01 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -55.44 -31.1 61.63 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.015 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -62.81 -30.37 71.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.308 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -157.98 54.32 0.38 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.672 -178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.469 ' HG2' HG22 ' A' ' 76' ' ' ILE . 50.7 mtmt -52.19 -56.35 15.16 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.272 0.558 . . . . 0.0 111.432 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -69.28 -8.66 48.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.609 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -98.41 0.34 45.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.79 0.329 . . . . 0.0 110.903 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.652 -0.69 . . . . 0.0 110.455 178.623 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.49 ' O ' HG13 ' A' ' 5' ' ' ILE . 72.6 mtp . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 119.515 -0.279 . . . . 0.0 111.624 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -51.91 -56.31 14.89 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 117.986 0.357 . . . . 0.0 111.395 -175.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.93 -40.62 96.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.325 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.6 m -55.4 -41.86 73.29 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.904 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 75.5 mt -67.08 -55.45 17.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.061 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -64.6 -23.1 67.15 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.863 0.364 . . . . 0.0 110.804 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.75 -42.01 64.5 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.966 177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.9 tt -60.08 -31.06 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.209 -175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -51.56 -30.35 20.41 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.749 0.309 . . . . 0.0 111.438 177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.57 -30.51 52.63 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.4 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.6 ptmt -110.88 -16.15 13.62 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -170.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' HB2' HG12 ' A' ' 8' ' ' ILE . 32.4 m-85 -128.29 -35.22 2.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.675 0.274 . . . . 0.0 110.887 176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.89 126.38 41.66 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.345 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -84.2 34.85 0.52 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.028 0.442 . . . . 0.0 110.472 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.3 tp -73.49 122.63 88.1 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.229 -177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.597 ' HD2' HD12 ' A' ' 15' ' ' LEU . 61.0 Cg_endo -74.58 -5.01 16.29 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.768 2.312 . . . . 0.0 111.571 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.511 HG23 ' HD2' ' A' ' 18' ' ' PRO . 3.2 m -116.74 142.66 30.04 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.244 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 21' ' ' THR . 25.7 Cg_endo -62.95 140.83 81.51 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.984 1.789 . . . . 0.0 112.191 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.8 t -70.2 -9.96 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.536 0.684 . . . . 0.0 110.108 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -79.41 -17.81 53.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 122.055 0.931 . . . . 0.0 108.99 179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.8 m -81.62 -23.27 37.12 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.053 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.534 HD12 HD22 ' A' ' 28' ' ' LEU . 17.5 pt -108.47 -168.34 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.596 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.447 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.54 171.55 16.83 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.321 -177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.541 ' HA ' HD12 ' A' ' 66' ' ' ILE . 2.5 m-20 -57.93 -28.16 64.03 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.269 0.557 . . . . 0.0 111.24 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.619 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 24.9 mt-10 -104.32 7.52 35.78 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.584 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.66 141.33 30.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.568 0.223 . . . . 0.0 111.156 -176.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -64.18 94.46 0.11 Allowed 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD22 HD12 ' A' ' 22' ' ' ILE . 49.9 mt -51.61 -42.67 62.15 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.918 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 45.1 p90 -62.11 -26.83 68.52 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.528 -177.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.27 -25.56 66.12 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.946 0.403 . . . . 0.0 110.941 -178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.32 -22.01 55.49 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.332 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 15.43 3.49 Favored Glycine 0 N--CA 1.454 -0.152 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.345 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 32.2 tp -64.48 107.17 1.3 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 51.8 m -93.97 174.61 7.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.678 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.9 p -48.88 -67.88 0.23 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.592 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -58.0 -34.88 70.47 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.19 -178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.4 -38.49 89.86 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.7 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 21.5 m -73.76 -50.13 22.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.252 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.44 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 85.9 t -56.27 -36.46 46.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.642 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.7 tp60 -62.94 -38.73 92.22 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.273 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HB2' HG23 ' A' ' 8' ' ' ILE . 1.1 pp -67.16 -29.1 68.7 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' SER . 35.4 mtt -72.12 -46.59 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.174 -177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 39' ' ' VAL . 58.8 mt -54.04 -45.73 71.69 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.859 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -73.93 -40.42 43.96 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.164 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.49 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -61.51 -27.38 41.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 120.471 0.177 . . . . 0.0 111.176 -178.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -56.44 -55.38 34.34 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.912 0.387 . . . . 0.0 110.463 177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -70.76 -29.61 65.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.589 -178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.17 -50.67 61.36 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.269 -175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.5 p90 -128.54 -33.97 2.05 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.407 ' OD2' HD12 ' A' ' 51' ' ' ILE . 27.1 t70 -177.6 -68.85 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 118.493 0.588 . . . . 0.0 112.193 -174.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.58 173.49 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 CA-C-O 120.868 0.366 . . . . 0.0 111.037 -178.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.06 168.39 9.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.231 173.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HB3' HD11 ' A' ' 57' ' ' LEU . 66.6 m-85 -59.61 119.39 39.81 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.108 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -60.26 148.25 90.7 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.936 2.424 . . . . 0.0 113.199 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.19 -28.87 56.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.307 -178.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -52.26 -39.78 60.83 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.374 -179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.6 pp -112.64 -2.8 14.45 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.433 -176.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' A' ' 59' ' ' ASN . 4.5 tt -70.95 80.23 0.65 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.237 -176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 27.2 t-20 164.63 -35.13 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.0 109.67 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -72.24 162.09 29.95 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.483 -0.781 . . . . 0.0 112.129 -173.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.12 -8.82 3.76 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.413 -0.812 . . . . 0.0 113.077 -173.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 m -48.94 -34.62 13.24 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -64.39 -26.68 68.57 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.559 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.427 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -67.58 -26.66 66.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.03 0.443 . . . . 0.0 111.043 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.0 m -117.26 87.8 2.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.872 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.541 HD12 ' HA ' ' A' ' 24' ' ' ASP . 61.7 mt -56.65 -45.14 82.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.932 -175.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.619 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -57.42 -28.32 63.18 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.431 179.31 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.35 -51.43 7.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.949 0.404 . . . . 0.0 110.879 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG22 ' HA ' ' A' ' 66' ' ' ILE . 16.9 tt -66.61 -31.29 52.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.399 -174.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.505 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.2 pp20? -60.63 -29.32 69.17 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.326 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -71.32 -40.8 70.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.885 175.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.7 m -64.51 -37.85 88.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.993 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.563 HG23 HD12 ' A' ' 76' ' ' ILE . 12.8 p -74.35 -28.99 23.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-O 120.557 0.218 . . . . 0.0 110.513 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.8 mtmm -56.95 -40.12 75.85 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.246 0.546 . . . . 0.0 110.426 173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 94.5 mt -52.19 -30.38 26.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.308 178.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.563 HD12 HG23 ' A' ' 73' ' ' VAL . 54.1 mt -68.35 -43.75 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.95 0.405 . . . . 0.0 110.114 177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.06 -31.54 72.7 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.976 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -72.37 -37.29 68.81 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.51 177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -114.1 45.52 1.3 Allowed Glycine 0 C--N 1.331 0.296 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.601 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.543 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 8.0 mmpt? -55.5 -46.26 76.96 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.713 0.768 . . . . 0.0 110.195 176.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.32 -13.59 20.44 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.345 -1.298 . . . . 0.0 111.826 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.84 -23.91 12.96 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.727 0.299 . . . . 0.0 111.105 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 110.591 -178.229 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.466 ' O ' HG13 ' A' ' 5' ' ' ILE . 43.8 mtp . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 111.598 0.222 . . . . 0.0 111.598 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -56.15 -46.53 79.24 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.602 0.239 . . . . 0.0 111.484 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -65.66 -42.17 91.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.232 0.539 . . . . 0.0 109.882 178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.7 m -54.01 -44.05 70.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.995 176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.574 ' O ' HG22 ' A' ' 8' ' ' ILE . 85.7 mt -65.87 -47.55 85.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.217 -0.901 . . . . 0.0 111.505 -176.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -70.22 -29.95 66.9 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.99 0.424 . . . . 0.0 110.452 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -74.25 -36.99 63.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.5 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 12' ' ' PHE . 13.5 tt -58.56 -31.95 44.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.453 -174.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.511 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -53.92 -26.95 27.85 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.751 0.31 . . . . 0.0 111.357 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.08 -30.29 62.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.65 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 18.1 ptmt -111.41 -24.13 10.37 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.585 ' HB2' HG12 ' A' ' 8' ' ' ILE . 49.0 m-85 -127.08 -1.29 6.48 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.326 -0.233 . . . . 0.0 111.524 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.25 124.15 8.09 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -78.35 53.34 1.25 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.439 0.638 . . . . 0.0 110.296 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.59 HD12 ' HD2' ' A' ' 16' ' ' PRO . 42.3 tp -87.83 121.92 70.52 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.466 177.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HD2' HD12 ' A' ' 15' ' ' LEU . 90.1 Cg_endo -80.53 22.38 0.78 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.945 2.43 . . . . 0.0 112.307 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 18' ' ' PRO . 2.7 m -149.52 140.03 13.8 Favored Pre-proline 0 N--CA 1.443 -0.821 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -176.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' O ' HG22 ' A' ' 21' ' ' THR . 22.5 Cg_endo -61.09 125.8 17.94 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.545 2.163 . . . . 0.0 112.191 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.2 t -60.07 -21.55 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-O 121.274 0.559 . . . . 0.0 110.427 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -32.78 67.22 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.93 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.6 t -79.36 -23.52 43.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.713 0.292 . . . . 0.0 111.011 -175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.8 pt -100.51 -174.84 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.67 169.68 23.77 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.65 0.262 . . . . 0.0 110.673 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.88 -26.41 67.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.826 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -98.48 7.76 45.75 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.335 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.45 164.52 12.87 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.043 0.449 . . . . 0.0 111.307 -175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -72.27 94.84 1.63 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.754 -178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 66' ' ' ILE . 54.6 mt -58.14 -50.42 73.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.388 0.614 . . . . 0.0 110.931 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 22.5 p90 -60.78 -22.05 63.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.912 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.36 -32.44 72.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.802 0.334 . . . . 0.0 110.507 178.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.96 -13.73 62.11 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.236 0.541 . . . . 0.0 110.656 177.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.34 12.38 8.98 Favored Glycine 0 C--O 1.236 0.281 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.954 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.91 111.41 1.47 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.788 0.328 . . . . 0.0 110.183 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -95.32 168.92 10.43 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.6 p -54.38 -54.33 41.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.093 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -59.6 -42.49 92.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.943 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.33 -36.15 82.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.438 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -76.73 -52.34 9.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.277 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -57.54 -30.17 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-O 120.841 0.353 . . . . 0.0 111.142 -178.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -66.02 -31.79 72.88 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.065 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' O ' HD13 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -62.57 -29.31 70.49 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.042 0.449 . . . . 0.0 109.984 -177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.405 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 42.2 mtm -67.29 -40.71 86.11 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.596 -176.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 76.7 mt -58.29 -43.83 88.23 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.879 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.16 -33.76 43.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.025 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.508 HG12 HG21 ' A' ' 8' ' ' ILE . 0.9 OUTLIER -67.42 -27.08 37.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 O-C-N 122.909 -0.171 . . . . 0.0 110.918 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 31.5 tt0 -57.29 -55.61 32.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.112 0.482 . . . . 0.0 110.298 175.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.64 66.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.2 -50.51 64.54 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.364 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.468 ' CE2' HG23 ' A' ' 45' ' ' ILE . 52.1 p90 -128.57 -34.76 1.98 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' OD2' HG23 ' A' ' 51' ' ' ILE . 10.7 t70 -178.64 -66.96 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 118.45 0.568 . . . . 0.0 111.788 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.78 172.17 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 121.056 0.455 . . . . 0.0 111.637 -177.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -108.82 168.65 9.2 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.616 176.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.693 ' HB3' HD11 ' A' ' 57' ' ' LEU . 22.7 m-85 -58.4 125.94 77.22 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.515 -178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -70.81 150.5 61.9 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.607 2.205 . . . . 0.0 112.395 -176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.421 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 18.8 t70 -48.19 -31.6 5.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.697 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -51.39 -43.11 61.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.573 -178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -111.32 8.56 21.44 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.5 mt -66.23 142.55 57.66 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.079 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.38 78.91 0.19 Allowed 'General case' 0 N--CA 1.465 0.318 0 O-C-N 123.601 0.563 . . . . 0.0 109.924 -173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -153.2 160.74 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.682 -171.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -53.68 -29.22 37.84 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.374 0.421 . . . . 0.0 111.035 178.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.8 m -53.23 -37.89 62.45 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.588 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -69.17 -24.29 64.05 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.662 0.267 . . . . 0.0 111.342 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -85.37 0.3 52.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.731 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.597 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.7 m -149.72 94.13 2.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.259 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 24' ' ' ASP . 64.7 mt -57.03 -45.7 83.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.992 -176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.597 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.71 -27.93 53.02 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 120.856 0.36 . . . . 0.0 111.373 178.633 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.55 -45.79 15.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.861 0.363 . . . . 0.0 111.164 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.522 HG22 ' HA ' ' A' ' 66' ' ' ILE . 17.2 tt -72.28 -32.32 42.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.259 -176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.64 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.9 OUTLIER -63.28 -32.0 73.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.88 0.371 . . . . 0.0 110.137 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -68.47 -34.02 75.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 109.838 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.613 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 25.3 m -74.93 -31.24 61.47 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.617 -178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.64 HG12 ' O ' ' A' ' 70' ' ' GLU . 7.2 p -69.52 -29.16 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.247 -177.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -48.17 80.22 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.336 -0.228 . . . . 0.0 111.424 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -59.27 -28.47 66.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.627 0.251 . . . . 0.0 111.015 -177.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 75' ' ' LEU . 60.8 mt -56.32 -47.35 81.35 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.194 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD13 ' HG3' ' A' ' 80' ' ' LYS . 3.8 mm? -70.7 -30.46 67.02 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.569 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -61.17 -42.0 97.78 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.956 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -122.22 45.22 1.23 Allowed Glycine 0 C--N 1.328 0.139 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.539 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -71.05 -48.26 53.81 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.218 0.607 . . . . 0.0 111.533 -174.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -67.0 -47.14 72.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.721 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.83 74.18 10.52 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.442 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.184 -178.962 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.425 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.7 mtp . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -58.75 -47.82 83.33 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.73 -38.89 77.02 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.1 m -52.67 -47.92 66.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.819 177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 55.5 mt -65.61 -56.62 14.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.012 -0.994 . . . . 0.0 111.241 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.437 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 4.5 ppt_? -62.51 -23.98 67.24 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.835 0.35 . . . . 0.0 110.847 -178.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 33.1 tt0 -72.79 -38.71 67.16 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.869 178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 4.9 tt -61.05 -31.04 48.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 120.768 0.318 . . . . 0.0 111.297 -173.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.68 -26.92 36.51 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.368 178.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.09 -30.35 63.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.84 0.353 . . . . 0.0 111.256 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 13.5 ptmt -108.84 -66.26 1.07 Allowed 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.921 -173.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.594 ' HB2' HG12 ' A' ' 8' ' ' ILE . 44.7 m-85 -78.79 -32.37 46.41 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.904 0.383 . . . . 0.0 110.489 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -59.81 114.07 5.94 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.196 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.48 HE21 ' HG2' ' A' ' 40' ' ' GLN . 79.5 mm-40 -79.55 43.77 0.58 Allowed 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.1 tp -78.84 130.08 71.5 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.242 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 15' ' ' LEU . 85.7 Cg_endo -79.79 1.09 9.51 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.727 2.285 . . . . 0.0 112.221 -178.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.497 HG23 ' HD2' ' A' ' 18' ' ' PRO . 18.7 m -131.29 140.32 38.15 Favored Pre-proline 0 N--CA 1.444 -0.748 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.86 -175.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' O ' HG22 ' A' ' 21' ' ' THR . 18.5 Cg_endo -57.84 138.57 86.69 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.64 2.227 . . . . 0.0 112.587 -177.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.425 HG13 HD11 ' A' ' 22' ' ' ILE . 61.9 t -67.38 -15.91 20.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.458 -179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.36 -28.69 67.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.693 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.536 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.0 t -91.72 -10.43 40.13 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -174.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.655 HD12 HD22 ' A' ' 28' ' ' LEU . 23.4 pt -104.72 169.86 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.55 0.214 . . . . 0.0 110.478 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.438 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -154.5 175.28 13.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.609 -176.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.563 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.4 p-10 -64.83 -31.21 72.33 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.268 -0.423 . . . . 0.0 112.019 -174.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.3 13.39 34.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.076 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.438 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -110.24 133.72 52.96 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' HB2' ' CE2' ' A' ' 29' ' ' TYR . 15.9 p-10 -66.79 106.28 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.474 0.654 . . . . 0.0 110.462 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.655 HD22 HD12 ' A' ' 22' ' ' ILE . 19.3 mt -61.42 -31.98 71.92 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.915 -174.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.1 p90 -63.94 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.225 -177.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.438 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -63.24 -36.43 83.62 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.866 0.365 . . . . 0.0 110.327 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.59 -14.17 60.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.605 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 113.44 25.94 4.16 Favored Glycine 0 C--N 1.329 0.171 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.962 176.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 48.9 tp -65.86 106.71 1.61 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.4 p -94.5 173.77 7.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.774 -176.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.1 p -52.97 -53.94 42.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.246 175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -58.6 -47.01 85.77 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.918 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.42 86.05 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.652 -177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.607 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 p -74.82 -46.02 39.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.943 -178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' SD ' ' A' ' 42' ' ' MET . 94.1 t -62.56 -34.52 65.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.049 0.452 . . . . 0.0 110.504 178.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.48 ' HG2' HE21 ' A' ' 14' ' ' GLN . 55.1 tp60 -66.5 -35.48 80.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.258 -177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.607 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.2 pp -71.13 -22.0 62.12 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.455 ' HG3' ' O ' ' A' ' 38' ' ' SER . 60.2 mtp -67.97 -55.94 10.82 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.831 -178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.5 pp -58.91 -31.72 68.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.377 -175.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -78.34 -35.02 34.67 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.998 177.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.507 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.9 OUTLIER -72.6 -27.52 25.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.643 0.259 . . . . 0.0 110.784 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -55.8 -54.84 39.59 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.168 0.508 . . . . 0.0 110.032 176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.89 -30.09 68.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.655 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.48 -50.57 71.37 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.507 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.1 p90 -128.24 -33.62 2.15 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.451 ' OD2' HG23 ' A' ' 51' ' ' ILE . 22.6 t70 -177.34 -70.83 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 118.33 0.514 . . . . 0.0 112.204 -176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.568 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.43 173.65 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 120.801 0.334 . . . . 0.0 111.017 -178.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.01 168.2 9.21 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.416 175.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.664 ' HB3' HD11 ' A' ' 57' ' ' LEU . 53.0 m-85 -64.94 125.2 88.59 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.338 -174.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.5 156.41 64.09 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.918 2.412 . . . . 0.0 112.924 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -54.53 -35.68 63.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.437 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 m-80 -53.62 -37.66 63.27 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.917 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.664 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -113.77 1.41 14.83 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 121.343 -0.143 . . . . 0.0 111.239 -177.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.4 tt -68.51 79.21 0.27 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -137.07 151.08 48.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.734 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.77 -36.13 62.04 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 123.423 0.452 . . . . 0.0 110.403 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 61' ' ' LYS . 3.2 tmmm? -53.36 -53.64 48.18 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.044 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.6 m -61.87 -47.74 83.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.854 -174.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -64.59 -29.81 70.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.069 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.61 -49.92 60.69 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.797 0.332 . . . . 0.0 110.721 178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.8 p -93.03 86.76 5.51 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.29 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 65.3 mt -56.69 -45.84 82.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.539 -175.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.456 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -58.29 -28.43 64.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.825 0.345 . . . . 0.0 111.028 -178.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -80.51 -49.47 11.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.936 0.398 . . . . 0.0 110.507 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.2 tt -66.08 -32.68 59.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.179 -176.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -66.81 -30.02 70.11 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.943 0.402 . . . . 0.0 110.153 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HA ' ' HD2' ' A' ' 74' ' ' LYS . 20.0 t70 -80.4 -39.73 27.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.273 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.601 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 27.8 m -66.64 -30.82 71.17 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.627 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.43 HG23 HD12 ' A' ' 76' ' ' ILE . 13.2 p -72.78 -27.92 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 O-C-N 121.968 -0.458 . . . . 0.0 110.995 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.527 ' HD2' ' HA ' ' A' ' 71' ' ' ASP . 87.1 mttt -60.13 -43.76 95.44 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.753 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -60.14 -28.14 67.65 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.975 -178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -58.88 -54.06 39.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-O 121.192 0.52 . . . . 0.0 110.022 175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.2 mt -62.5 -29.93 70.91 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.394 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -70.6 -40.85 72.97 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.444 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -68.63 -21.94 74.96 Favored Glycine 0 C--N 1.331 0.255 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.766 -177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 75.0 mttt -61.17 -43.07 99.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.255 176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -79.13 -45.75 19.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.072 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.78 77.14 2.72 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.669 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.687 179.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.565 ' SD ' HD11 ' A' ' 77' ' ' LEU . 52.0 ttp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 120.292 0.092 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -60.58 -46.05 91.67 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.766 0.317 . . . . 0.0 110.771 -178.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.43 -31.38 57.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.003 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.6 m -52.92 -39.3 62.69 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.617 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.7 mt -54.66 -60.31 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.13 177.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.44 ' HB3' HD13 ' A' ' 66' ' ' ILE . 24.1 ptt180 -68.63 -23.87 64.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.531 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.535 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 35.0 tt0 -68.49 -39.08 81.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.1 tt -66.25 -32.67 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 121.024 -0.271 . . . . 0.0 110.755 -176.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.22 -26.59 67.84 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.695 0.284 . . . . 0.0 111.077 178.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.12 -29.48 57.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.57 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 32.1 pttt -109.57 -53.04 2.71 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -175.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.655 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.3 m-85 -89.59 -35.4 15.89 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.832 0.349 . . . . 0.0 111.233 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.449 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -64.45 114.26 6.64 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.965 -178.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 18.2 mt-30 -75.75 70.95 2.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.134 0.492 . . . . 0.0 110.137 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.4 tp -98.05 131.77 25.9 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.021 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.1 Cg_endo -72.16 -17.85 27.59 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.271 1.98 . . . . 0.0 110.982 -176.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 28.7 m -110.19 138.88 20.96 Favored Pre-proline 0 N--CA 1.44 -0.944 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.484 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 36.2 Cg_endo -65.98 123.32 11.13 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.344 2.029 . . . . 0.0 111.714 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.425 ' HA ' HG12 ' A' ' 22' ' ' ILE . 94.0 t -56.57 -25.29 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.149 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -54.41 -28.71 45.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.161 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.6 t -87.4 -23.43 24.53 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.488 0.185 . . . . 0.0 111.273 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.486 HG21 ' HB2' ' A' ' 31' ' ' ALA . 25.3 pt -98.27 -175.74 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -160.02 176.58 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.666 0.269 . . . . 0.0 110.378 -177.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.561 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 9.5 p-10 -66.11 -24.22 66.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.07 -178.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.77 -5.02 52.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.169 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -97.55 160.2 14.46 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -76.9 89.95 3.5 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.315 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.7 mt -54.29 -43.23 70.91 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.289 0.566 . . . . 0.0 110.991 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.523 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 29.8 p90 -63.63 -24.0 67.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.526 -178.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.24 -32.78 61.21 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.812 0.339 . . . . 0.0 110.343 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -70.05 -24.45 63.26 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.354 177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.67 32.86 0.73 Allowed Glycine 0 C--O 1.235 0.167 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.999 174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.1 tp -61.73 111.53 1.9 Allowed 'General case' 0 C--O 1.235 0.29 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 25.5 m -118.81 161.94 19.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.242 -177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.443 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.9 m -48.4 -48.51 36.92 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 123.639 0.587 . . . . 0.0 111.899 -175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -58.76 -32.72 69.53 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 111.367 -177.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -78.47 -42.63 29.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.953 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 42' ' ' MET . 51.9 p -71.18 -46.47 61.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.173 -175.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 35' ' ' SER . 97.0 t -56.56 -51.0 70.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.849 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -61.24 -35.06 76.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.485 -177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD22 HD21 ' A' ' 9' ' ' LEU . 0.1 OUTLIER -57.89 -39.92 79.02 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.877 176.871 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 38' ' ' SER . 27.7 mtm -65.46 -52.67 51.33 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -59.56 -45.33 92.16 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.105 -177.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.519 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -66.75 -43.73 91.08 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.0 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 49' ' ' PHE . 1.1 mm -66.23 -33.11 61.37 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 120.707 0.289 . . . . 0.0 110.882 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -59.2 -54.51 46.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.153 0.502 . . . . 0.0 110.526 178.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -69.88 -29.2 66.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.605 179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.54 -50.82 72.43 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' CE1' ' SD ' ' A' ' 1' ' ' MET . 29.9 p90 -127.19 -33.87 2.36 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 -175.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.0 t70 -177.65 -68.9 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 118.353 0.524 . . . . 0.0 111.553 -179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.42 169.79 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 CA-C-O 120.99 0.424 . . . . 0.0 111.416 -176.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.0 169.11 9.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.251 174.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' HE2' HD11 ' A' ' 41' ' ' LEU . 47.7 m-85 -67.11 124.84 89.89 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.646 -177.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -66.1 150.79 84.98 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.846 2.364 . . . . 0.0 112.861 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -54.16 -31.38 52.4 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.658 -176.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.4 t-20 -50.57 -45.81 57.38 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.234 -178.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -108.41 -2.61 18.94 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.558 -176.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.52 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 5.3 tt -58.71 -42.21 88.15 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.946 0.403 . . . . 0.0 110.714 -175.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -93.9 15.8 15.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.063 0.458 . . . . 0.0 111.049 -175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.685 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.8 mmp_? -112.97 177.36 4.65 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.063 0.459 . . . . 0.0 111.733 -173.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -59.86 -8.98 2.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.614 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 39.8 m -53.9 -36.11 62.35 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 120.727 0.298 . . . . 0.0 111.26 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 18.8 m-85 -83.97 -8.75 59.08 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.86 0.362 . . . . 0.0 111.197 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -93.47 -6.54 46.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.678 177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.507 ' HB2' ' HE3' ' A' ' 67' ' ' LYS . 22.9 p -154.8 97.97 2.01 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.19 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.58 ' HA ' HG22 ' A' ' 69' ' ' ILE . 72.3 mt -61.74 -42.2 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.588 -174.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.507 ' HE3' ' HB2' ' A' ' 65' ' ' SER . 0.4 OUTLIER -54.78 -27.82 44.36 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.8 0.333 . . . . 0.0 111.062 179.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.28 -41.76 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.12 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.58 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.0 tt -73.11 -36.15 49.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.711 -176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -63.93 -36.85 85.29 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -55.89 -41.15 74.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.51 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.7 m -74.0 -40.86 62.64 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.426 -177.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.544 HG12 ' HA ' ' A' ' 70' ' ' GLU . 9.5 p -66.6 -30.48 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 CA-C-O 120.812 0.339 . . . . 0.0 110.704 -177.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 28.4 mtpp -62.01 -39.38 92.07 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.292 0.567 . . . . 0.0 109.556 173.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.06 -32.29 72.54 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.726 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 73' ' ' VAL . 73.4 mt -60.0 -45.2 95.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.565 HD11 ' SD ' ' A' ' 1' ' ' MET . 75.4 mt -68.76 -32.14 71.69 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.975 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.01 -21.93 63.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.312 0.577 . . . . 0.0 109.789 175.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.94 7.78 81.04 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.943 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.438 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.3 mmmt -75.16 -51.54 13.16 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 59.18 32.48 22.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.673 178.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.95 72.26 3.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.004 176.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.274 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.675 -176.78 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.2 mtp . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 119.879 -0.105 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -53.54 -47.87 69.61 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.77 0.319 . . . . 0.0 111.575 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.91 -36.48 49.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.08 0.467 . . . . 0.0 110.158 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.6 m -53.45 -45.43 69.51 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.196 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.521 ' O ' HG22 ' A' ' 8' ' ' ILE . 70.3 mt -63.1 -47.01 94.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.627 -175.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -73.29 -27.31 61.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.05 0.453 . . . . 0.0 110.226 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -71.1 -39.63 71.99 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.951 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 12' ' ' PHE . 12.9 tt -56.3 -32.52 35.44 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 120.747 0.308 . . . . 0.0 111.387 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD21 HD22 ' A' ' 41' ' ' LEU . 4.1 mm? -56.18 -31.96 63.9 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.285 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.77 -30.35 71.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.753 0.311 . . . . 0.0 111.661 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.9 pttm -110.8 -61.09 1.73 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.582 ' HB2' HG12 ' A' ' 8' ' ' ILE . 61.6 m-85 -78.76 -24.47 44.71 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.679 0.276 . . . . 0.0 111.297 -177.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -75.08 121.04 6.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.044 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -83.91 66.01 8.93 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 121.493 0.664 . . . . 0.0 109.933 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD12 ' HD2' ' A' ' 16' ' ' PRO . 19.8 tp -95.88 132.26 27.49 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.57 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 15' ' ' LEU . 60.9 Cg_endo -74.37 -15.74 22.26 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.55 2.167 . . . . 0.0 111.308 -178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 15.5 m -109.5 140.57 22.24 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.472 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.576 ' O ' HG22 ' A' ' 21' ' ' THR . 22.4 Cg_endo -61.82 120.7 8.44 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.177 1.918 . . . . 0.0 111.7 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.49 ' HA ' HG12 ' A' ' 22' ' ' ILE . 59.6 t -58.78 -22.12 20.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.24 0.543 . . . . 0.0 110.806 -178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -58.34 -26.98 63.72 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.687 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.576 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.0 t -87.04 -24.19 24.7 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.601 0.238 . . . . 0.0 111.319 -177.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.614 HD12 ' HG ' ' A' ' 28' ' ' LEU . 38.6 pt -95.89 -175.95 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.456 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -162.63 173.66 13.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.171 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 11.3 p-10 -66.42 -24.13 66.41 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.741 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -83.66 -13.42 54.23 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.066 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.456 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -101.04 153.66 19.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.808 -175.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -75.53 99.46 4.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.614 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.3 mp -55.51 -39.06 70.02 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.188 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.496 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 50.7 p90 -65.09 -26.79 68.37 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.153 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.49 -24.89 64.73 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.954 0.407 . . . . 0.0 110.691 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.438 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -77.76 -24.19 49.06 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.161 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 46.8 0.34 Allowed Glycine 0 CA--C 1.517 0.192 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.211 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 46.1 tp -81.46 122.81 27.99 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.713 0.292 . . . . 0.0 110.347 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 42.0 t -108.01 169.26 8.73 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.158 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.3 m -55.95 -41.91 75.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.198 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -60.61 -40.4 91.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.077 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -75.86 -39.87 55.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.299 -178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.674 ' HA ' HD23 ' A' ' 41' ' ' LEU . 16.9 p -71.04 -51.41 25.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.306 -176.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 97.2 t -57.65 -42.94 82.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.883 0.373 . . . . 0.0 111.031 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -65.16 -34.07 77.5 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.239 -178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.674 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -59.86 -32.92 71.15 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.551 ' SD ' HD22 ' A' ' 58' ' ' LEU . 26.0 mtm -73.88 -49.08 26.61 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.21 -43.43 67.21 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.563 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.3 -35.19 34.33 Favored Glycine 0 CA--C 1.52 0.379 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.355 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.56 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -63.68 -27.52 43.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 122.745 -0.267 . . . . 0.0 111.213 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.584 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 40.8 tt0 -57.41 -56.73 18.14 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.894 0.378 . . . . 0.0 110.581 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -67.75 -29.59 68.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.394 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -49.6 71.59 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.204 -177.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.56 ' CE2' HG23 ' A' ' 45' ' ' ILE . 41.7 p90 -128.47 -33.05 2.14 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.0 t70 -179.02 -72.56 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 118.751 0.705 . . . . 0.0 112.031 -176.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.584 ' HA ' ' HG3' ' A' ' 46' ' ' GLU . 0.1 OUTLIER -135.1 168.54 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 120.605 0.24 . . . . 0.0 110.749 -178.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.26 168.32 9.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.848 176.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.661 ' HB3' HD11 ' A' ' 57' ' ' LEU . 47.4 m-85 -65.84 128.0 93.5 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.127 -174.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -72.24 150.45 53.26 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.016 2.477 . . . . 0.0 112.071 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.569 ' HA ' ' HG ' ' A' ' 58' ' ' LEU . 4.9 p-10 -55.8 -30.55 61.52 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.895 -174.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -57.29 -23.55 49.14 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -123.86 5.07 8.74 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.678 0.622 . . . . 0.0 112.678 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 55' ' ' ASP . 61.3 mt -63.74 -57.8 8.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.923 0.392 . . . . 0.0 110.875 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -78.0 80.73 4.43 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG3' ' H ' ' A' ' 61' ' ' LYS . 5.7 tpp85 -158.68 169.95 23.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.864 -175.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.677 ' HZ2' ' HB2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -66.92 -9.36 37.42 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 122.578 0.351 . . . . 0.0 111.161 173.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.4 p -44.12 -58.75 2.67 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.397 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 55.4 m-85 -64.82 -33.43 75.96 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.714 0.292 . . . . 0.0 111.437 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.15 -24.41 67.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.953 0.406 . . . . 0.0 110.793 178.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.627 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 19.3 m -131.55 82.04 2.01 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.83 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.624 ' HA ' HG22 ' A' ' 69' ' ' ILE . 56.3 mt -56.09 -37.96 51.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.504 -175.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.627 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -55.64 -28.26 54.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.76 0.314 . . . . 0.0 111.151 177.746 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.0 -47.22 12.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.889 0.376 . . . . 0.0 110.943 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.624 HG22 ' HA ' ' A' ' 66' ' ' ILE . 12.1 tt -65.57 -31.95 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.322 -174.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -61.18 -33.72 73.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.005 0.431 . . . . 0.0 109.992 -179.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -74.14 -38.85 63.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.938 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.4 m -65.49 -37.03 85.62 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.245 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.472 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -75.37 -29.98 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.593 0.235 . . . . 0.0 110.71 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 60.9 mtpt -61.19 -34.98 75.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.887 0.375 . . . . 0.0 110.177 175.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.61 -30.64 68.83 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.664 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 HD12 HG23 ' A' ' 73' ' ' VAL . 68.1 mt -68.24 -50.56 56.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.783 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 4.1 mm? -55.72 -31.51 62.54 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.779 179.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.92 -43.16 62.74 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.198 177.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.31 24.0 34.02 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.142 -0.481 . . . . 0.0 113.675 -173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 77' ' ' LEU . 40.4 mtmt -71.52 -58.83 3.14 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 117.128 0.464 . . . . 0.0 111.46 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 64.17 87.52 0.11 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.279 -170.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -158.63 94.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.398 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.558 -0.734 . . . . 0.0 110.447 -177.542 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.749 0.309 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 12.4 p30 -71.35 -41.77 69.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.059 179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -58.94 -36.76 75.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.27 0.557 . . . . 0.0 110.059 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -56.93 -37.94 72.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.012 175.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.663 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.7 mt -66.58 -54.79 22.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.887 -178.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -63.75 -28.38 69.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.054 0.454 . . . . 0.0 110.004 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -67.99 -38.5 82.75 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.055 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 5' ' ' ILE . 6.3 tt -60.0 -31.67 48.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.84 -0.344 . . . . 0.0 110.846 -175.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.1 mm? -59.55 -26.63 65.52 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.135 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.52 -30.7 57.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.812 0.339 . . . . 0.0 111.134 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 15.9 ptmt -101.9 -59.59 1.68 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.833 -175.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.599 ' HB2' HG12 ' A' ' 8' ' ' ILE . 58.4 m-85 -92.96 -23.46 18.71 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.817 0.302 . . . . 0.0 111.817 -178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -65.37 107.59 1.98 Allowed Glycine 0 CA--C 1.517 0.173 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.226 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 52.9 tt0 -78.17 70.29 4.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.309 0.576 . . . . 0.0 110.345 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.544 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.6 tp -94.72 132.99 27.39 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.766 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.5 Cg_endo -74.61 -11.69 22.28 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.505 2.137 . . . . 0.0 111.35 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -112.84 141.73 25.98 Favored Pre-proline 0 N--CA 1.441 -0.919 0 CA-C-N 114.473 -1.24 . . . . 0.0 109.071 -179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 21' ' ' THR . 17.7 Cg_endo -60.51 121.75 10.22 Favored 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.151 1.901 . . . . 0.0 111.761 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.83 -22.75 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.423 0.63 . . . . 0.0 110.615 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -54.62 -26.04 30.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.035 178.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.0 t -88.37 -16.07 33.93 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -176.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.512 HD12 HD22 ' A' ' 28' ' ' LEU . 28.8 pt -104.91 178.25 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 120.579 0.228 . . . . 0.0 110.749 -178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.496 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.6 178.45 7.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.426 -176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -53.75 -37.58 63.54 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.061 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.571 ' HA ' ' HD2' ' A' ' 67' ' ' LYS . 42.1 mt-10 -93.39 -11.26 32.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.816 -175.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.496 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -79.66 146.73 32.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 -176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -76.48 98.45 4.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.931 0.396 . . . . 0.0 110.04 179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD22 HD12 ' A' ' 22' ' ' ILE . 40.9 mt -53.9 -43.58 69.79 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.751 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -63.53 -25.96 68.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.989 -177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.48 -29.36 65.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.867 0.365 . . . . 0.0 110.309 178.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.57 -24.08 53.53 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.152 175.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.72 29.33 1.89 Allowed Glycine 0 C--N 1.329 0.149 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.765 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.65 107.49 0.69 Allowed 'General case' 0 C--O 1.233 0.189 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -95.36 161.8 13.93 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.056 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.459 ' O ' HG23 ' A' ' 39' ' ' VAL . 27.8 p -52.26 -42.49 63.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.224 -177.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -53.71 -52.48 59.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.045 -178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 14' ' ' GLN . . . -62.93 -45.8 90.76 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.309 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.708 ' HA ' HD23 ' A' ' 41' ' ' LEU . 27.0 p -65.8 -32.37 73.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.496 -175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 35' ' ' SER . 93.8 t -77.41 -42.71 30.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.952 0.406 . . . . 0.0 110.175 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -58.62 -39.44 80.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.849 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.708 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.4 OUTLIER -62.02 -28.19 69.41 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.236 -177.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 44.1 mtt -67.92 -55.16 13.82 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.108 0.48 . . . . 0.0 109.932 -178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.4 mp -56.2 -43.65 78.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.813 -177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -69.92 -38.66 75.2 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.476 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.527 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.0 OUTLIER -69.54 -29.75 42.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.444 0.164 . . . . 0.0 111.229 -178.428 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -53.45 -55.6 23.86 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.221 0.534 . . . . 0.0 110.449 178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -72.23 -29.56 64.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.963 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.58 -50.41 65.65 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -173.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.9 p90 -129.34 -33.53 1.9 Allowed 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -174.61 -71.47 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 118.276 0.489 . . . . 0.0 112.234 -176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.19 170.96 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 120.791 0.329 . . . . 0.0 111.003 -177.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.7 168.31 9.23 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.54 174.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.521 ' HZ ' HG21 ' A' ' 5' ' ' ILE . 58.4 m-85 -60.54 127.72 87.21 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.849 -174.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.453 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 74.3 Cg_endo -71.54 157.14 56.83 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.861 2.374 . . . . 0.0 112.21 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.434 ' HA ' HD12 ' A' ' 58' ' ' LEU . 12.8 p-10 -52.87 -35.86 58.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.102 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -62.78 -5.81 3.12 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.668 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -142.24 14.86 2.04 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.768 175.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 52.6 mt -76.72 31.43 0.13 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.723 0.296 . . . . 0.0 111.361 177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -85.48 145.27 27.5 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 14.6 ptm180 -60.84 -26.28 67.24 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.156 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -68.56 -35.36 77.29 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.893 0.377 . . . . 0.0 110.56 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 14.5 m -67.56 -53.55 27.37 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.168 -177.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -59.58 -37.07 77.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -27.79 64.87 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.17 0.509 . . . . 0.0 110.792 176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.5 m -115.52 75.86 0.97 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.563 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.461 ' HA ' HG22 ' A' ' 69' ' ' ILE . 54.0 mt -50.25 -50.32 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.571 ' HD2' ' HA ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -49.04 -33.69 11.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.789 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.87 -52.8 6.39 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.968 0.414 . . . . 0.0 111.616 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.461 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.2 tt -69.18 -32.81 55.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.615 -172.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -61.5 -30.31 70.54 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.712 -177.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.567 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 17.5 t70 -83.46 -25.0 31.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.453 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.7 m -70.55 -39.82 73.75 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.317 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 5' ' ' ILE . 14.6 p -60.37 -29.56 44.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-O 120.93 0.395 . . . . 0.0 110.923 -179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.567 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 53.6 mtpt -59.39 -30.48 68.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.099 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.03 -33.68 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.495 -179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 52.8 mt -64.41 -36.82 78.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.267 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.408 HD13 ' HD3' ' A' ' 80' ' ' LYS . 3.9 mm? -72.99 -28.94 62.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.681 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -77.38 -40.44 43.79 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.032 0.444 . . . . 0.0 110.411 178.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -109.7 46.22 1.2 Allowed Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.86 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HD3' HD13 ' A' ' 77' ' ' LEU . 27.7 mmmt -43.86 -66.82 0.34 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.231 0.613 . . . . 0.0 112.319 -177.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -119.51 33.56 5.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.613 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -110.03 5.72 22.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.706 178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.592 -0.718 . . . . 0.0 110.737 -177.383 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.3 mtp . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 119.522 -0.275 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -52.19 -46.68 65.68 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 117.901 0.319 . . . . 0.0 111.858 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.22 -40.34 30.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.207 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -52.09 -43.43 63.89 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.404 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 8' ' ' ILE . 68.0 mt -62.48 -56.8 15.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.065 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -63.42 -25.81 68.45 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -72.98 -24.83 60.82 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.217 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.2 tt -76.21 -32.86 23.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.456 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.15 -33.81 65.56 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.777 0.323 . . . . 0.0 110.687 178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.35 -30.45 70.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.709 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.5 pttm -111.8 -58.79 2.08 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.539 ' HB2' HG12 ' A' ' 8' ' ' ILE . 15.4 m-85 -78.91 -31.21 45.21 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 122.319 -0.238 . . . . 0.0 111.591 -177.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -72.4 117.87 6.44 Favored Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.858 -0.686 . . . . 0.0 112.497 -177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -80.75 55.55 2.42 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.446 0.641 . . . . 0.0 110.324 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.559 HD12 ' HD2' ' A' ' 16' ' ' PRO . 25.5 tp -81.9 127.77 71.0 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.165 176.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.2 Cg_endo -76.38 -9.97 18.93 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.668 2.245 . . . . 0.0 111.752 -177.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.435 HG23 ' HD2' ' A' ' 18' ' ' PRO . 20.0 m -118.53 138.25 25.62 Favored Pre-proline 0 N--CA 1.442 -0.858 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.182 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' O ' HG22 ' A' ' 21' ' ' THR . 19.6 Cg_endo -58.58 124.51 15.96 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.316 2.011 . . . . 0.0 112.116 -176.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.9 t -56.77 -24.13 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-O 121.544 0.687 . . . . 0.0 110.125 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -55.43 -25.35 35.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.848 -1.069 . . . . 0.0 112.036 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 18' ' ' PRO . 3.3 t -89.89 -18.35 26.32 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.559 0.218 . . . . 0.0 111.489 -175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 HD12 ' HG ' ' A' ' 28' ' ' LEU . 27.2 pt -106.93 178.17 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.729 0.3 . . . . 0.0 110.561 -179.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.16 175.92 9.73 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.103 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -67.11 -30.01 69.91 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.095 0.474 . . . . 0.0 110.494 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -82.34 0.29 42.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.041 176.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.08 163.19 16.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.148 178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -87.82 95.17 9.99 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.516 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.1 mp -53.0 -41.9 65.08 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.827 -174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.546 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 35.3 p90 -62.3 -25.64 67.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.909 -176.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.77 -27.6 69.3 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.902 0.382 . . . . 0.0 110.632 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.6 -15.98 63.31 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.537 177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.13 42.38 1.0 Allowed Glycine 0 C--N 1.329 0.141 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.223 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 44.2 tp -84.09 115.29 22.3 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.754 0.312 . . . . 0.0 110.347 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 48.3 t -94.47 154.63 17.33 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.751 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.534 ' O ' HG23 ' A' ' 39' ' ' VAL . 13.7 t -60.94 -22.56 64.53 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.019 -176.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -68.29 -45.42 73.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.099 0.476 . . . . 0.0 109.916 177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.36 -33.96 77.2 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.897 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.733 ' HA ' HD23 ' A' ' 41' ' ' LEU . 60.3 p -71.69 -43.63 65.65 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.733 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 35' ' ' SER . 76.2 t -57.41 -41.1 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-O 121.151 0.501 . . . . 0.0 110.296 176.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -62.2 -37.37 85.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.286 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -67.05 -25.21 66.15 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.737 0.303 . . . . 0.0 110.208 -177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.508 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 19.1 mmt -71.68 -37.84 70.68 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.462 0.649 . . . . 0.0 109.466 -177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 tp -55.6 -51.29 67.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.509 -1.223 . . . . 0.0 110.872 -176.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.42 -31.83 44.72 Favored Glycine 0 CA--C 1.519 0.311 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.845 -178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -69.76 -29.08 39.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.727 -0.278 . . . . 0.0 111.281 -178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -54.53 -55.25 31.14 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.454 0.645 . . . . 0.0 110.463 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.59 -29.5 64.77 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.905 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.46 -49.74 54.3 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -128.67 -33.76 2.04 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.3 t70 -178.65 -62.4 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.138 0.426 . . . . 0.0 111.353 -177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -140.77 176.7 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.739 0.305 . . . . 0.0 110.732 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.7 168.75 9.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.261 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB3' HD11 ' A' ' 57' ' ' LEU . 31.3 m-85 -59.78 125.32 79.94 Favored Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.991 -177.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.5 149.9 84.29 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.9 2.4 . . . . 0.0 112.433 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -58.07 -22.68 51.43 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.348 -174.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.69 -34.0 73.7 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -114.68 6.8 15.77 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -174.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.6 mt -69.99 135.99 49.96 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 19.3 m120 64.07 28.58 14.25 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 123.706 0.629 . . . . 0.0 111.108 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 42.7 ttt180 -107.03 174.14 6.02 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.561 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' H ' ' HG2' ' A' ' 60' ' ' ARG . 17.4 ptpt -58.34 -14.92 8.53 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.5 p -53.68 -37.38 63.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.115 0.483 . . . . 0.0 110.723 177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -67.7 -26.08 65.99 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.066 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -74.49 -18.47 60.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.021 -179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.401 ' HB3' ' HE2' ' A' ' 67' ' ' LYS . 49.4 m -135.68 89.67 2.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.604 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.567 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.7 mm -56.74 -41.89 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.001 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.513 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.17 67.7 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.235 178.258 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.19 -42.18 19.35 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.02 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.567 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.6 tt -70.92 -32.04 47.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.913 -176.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.477 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.6 OUTLIER -62.72 -36.73 83.94 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -62.79 -46.53 87.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.256 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.4 m -62.34 -44.32 96.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.216 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 70' ' ' GLU . 14.3 p -69.67 -31.26 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.473 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -64.13 -33.98 77.01 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 110.389 174.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.2 mt -67.01 -33.35 75.36 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.277 -0.419 . . . . 0.0 109.999 175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' HB ' ' O ' ' A' ' 73' ' ' VAL . 71.1 mt -60.6 -47.62 92.09 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.173 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.791 175.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.496 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 4.6 mm? -55.9 -29.5 60.12 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.372 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -69.65 -32.39 71.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.832 0.349 . . . . 0.0 111.131 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.12 69.43 0.29 Allowed Glycine 0 N--CA 1.449 -0.469 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.496 ' HD2' ' HA ' ' A' ' 77' ' ' LEU . 2.8 mppt? -61.16 -50.45 73.1 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.922 0.392 . . . . 0.0 110.054 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 61.43 14.92 6.18 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.732 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -80.9 72.45 7.9 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.198 0.523 . . . . 0.0 109.924 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.041 -177.515 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.8 mtp . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 111.089 0.033 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -53.02 -44.82 67.6 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.735 0.302 . . . . 0.0 111.402 -173.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.53 -39.39 32.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.032 0.444 . . . . 0.0 110.295 178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.1 m -52.72 -42.24 64.68 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.422 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 8' ' ' ILE . 72.8 mt -68.43 -48.39 72.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.243 -175.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -63.47 -38.99 93.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.105 0.478 . . . . 0.0 110.154 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.585 ' HG2' ' HE2' ' A' ' 11' ' ' LYS . 41.4 tt0 -61.32 -40.45 94.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.189 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.602 HG12 ' HB2' ' A' ' 12' ' ' PHE . 8.4 tt -63.15 -32.08 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.816 -176.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -61.6 -31.88 71.97 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.791 0.329 . . . . 0.0 110.709 176.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.33 -30.59 54.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.967 -175.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HE2' ' HG2' ' A' ' 7' ' ' GLU . 47.2 pttt -111.5 -19.61 12.49 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.602 ' HB2' HG12 ' A' ' 8' ' ' ILE . 3.1 m-85 -122.21 -39.2 2.61 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.605 0.241 . . . . 0.0 111.186 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.4 131.18 29.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.675 -173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -77.57 72.28 4.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.672 0.748 . . . . 0.0 109.562 178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.598 HD12 ' HD2' ' A' ' 16' ' ' PRO . 31.4 tp -106.32 122.91 40.59 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.241 -0.89 . . . . 0.0 108.979 176.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 15' ' ' LEU . 69.3 Cg_endo -76.87 4.08 6.01 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.823 2.348 . . . . 0.0 111.814 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 18' ' ' PRO . 19.5 m -130.05 139.32 35.3 Favored Pre-proline 0 N--CA 1.44 -0.972 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.317 -175.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.617 ' O ' HG22 ' A' ' 21' ' ' THR . 25.9 Cg_endo -62.03 121.57 9.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.138 1.892 . . . . 0.0 111.937 -178.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 46.8 t -59.82 -17.44 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 121.36 0.6 . . . . 0.0 110.813 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.98 -32.03 73.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.442 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 18' ' ' PRO . 6.1 t -77.26 -22.95 51.33 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 120.661 0.267 . . . . 0.0 111.242 -176.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.454 HG21 ' HB2' ' A' ' 31' ' ' ALA . 24.4 pt -93.7 -175.35 0.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.525 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.02 -173.73 4.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.445 0.164 . . . . 0.0 110.692 -173.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 11.5 p-10 -65.54 -40.93 93.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.712 -175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.556 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 21.6 mt-10 -96.47 -7.53 34.54 Favored 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.525 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -77.4 137.76 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -62.73 102.0 0.3 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.955 -178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.525 ' HB3' HD12 ' A' ' 33' ' ' LEU . 58.9 mt -55.47 -45.28 76.94 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.358 -174.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.4 p90 -63.02 -23.47 67.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.659 -178.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.55 -27.38 67.69 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.845 0.355 . . . . 0.0 110.853 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -73.89 -13.77 60.96 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.291 0.567 . . . . 0.0 110.383 176.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.49 35.12 2.72 Favored Glycine 0 N--CA 1.453 -0.17 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.787 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD12 ' HB3' ' A' ' 28' ' ' LEU . 1.6 tt -74.19 115.48 13.73 Favored 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.2 m -95.45 160.02 14.72 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.239 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.1 p -52.69 -44.8 66.51 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.779 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -56.19 -49.37 74.23 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.362 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.38 -30.55 71.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.772 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 41' ' ' LEU . 24.9 m -73.28 -55.2 6.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.664 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.7 m -62.1 -34.01 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.02 0.438 . . . . 0.0 110.634 -178.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -66.41 -32.31 73.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.2 -177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.663 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.6 OUTLIER -73.52 -22.61 60.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.189 -177.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 mtm -70.66 -50.12 40.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.955 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.01 -46.99 75.26 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.579 -175.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -72.07 -32.19 63.44 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.216 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.532 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -71.88 -29.42 33.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.516 0.198 . . . . 0.0 111.385 -178.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -54.34 -55.91 23.8 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.38 0.61 . . . . 0.0 110.491 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -70.46 -28.96 65.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.695 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -49.93 65.59 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -175.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.532 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.9 p90 -128.08 -34.2 2.13 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.9 t70 -177.37 -66.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 118.464 0.574 . . . . 0.0 111.427 -176.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.575 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.25 170.3 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 120.877 0.37 . . . . 0.0 111.023 -177.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.56 167.83 10.1 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.778 172.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.603 ' HB3' HD11 ' A' ' 57' ' ' LEU . 54.0 m-85 -65.49 120.59 69.3 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.261 -174.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.53 148.45 87.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.72 2.28 . . . . 0.0 112.624 -176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -51.55 -28.05 12.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.021 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -55.92 -43.52 77.43 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -108.12 -6.54 16.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.844 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.423 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 4.3 tt -64.16 86.58 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.532 ' OD1' ' HG2' ' A' ' 60' ' ' ARG . 39.1 t-20 -158.2 151.35 22.93 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.507 -173.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' HG2' ' OD1' ' A' ' 59' ' ' ASN . 6.8 ptp180 -48.22 -31.28 5.61 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.144 0.577 . . . . 0.0 111.458 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -59.25 -45.87 90.01 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.485 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 69' ' ' ILE . 40.9 m -81.75 -37.34 27.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.936 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' HE1' ' HA ' ' A' ' 58' ' ' LEU . 24.8 m-85 -80.49 2.12 26.61 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.423 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.11 -46.83 69.82 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.021 0.439 . . . . 0.0 110.633 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 p -143.62 147.23 34.05 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.279 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 74.8 mt -66.39 -50.3 68.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -54.04 -28.75 40.59 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.735 0.302 . . . . 0.0 111.574 -173.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -74.89 -47.81 28.06 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 120.983 0.42 . . . . 0.0 110.862 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.436 ' HB ' ' O ' ' A' ' 62' ' ' SER . 17.3 tt -72.73 -37.53 55.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.494 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.2 OUTLIER -70.69 -31.52 68.43 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.786 0.327 . . . . 0.0 110.295 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -66.4 -38.11 86.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.217 0.532 . . . . 0.0 110.513 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -74.87 -39.39 61.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.535 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.8 p -65.45 -29.14 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.7 mttt -58.8 -39.09 80.09 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.005 0.431 . . . . 0.0 110.361 176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.32 -31.82 73.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.771 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.15 -38.52 82.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.164 0.507 . . . . 0.0 110.098 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' O ' ' HG2' ' A' ' 80' ' ' LYS . 61.9 mt -76.59 -28.65 56.25 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.694 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.33 -49.9 75.13 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 174.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -104.49 59.99 0.44 Allowed Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.945 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 77' ' ' LEU . 26.1 mmmt -51.07 -64.45 0.81 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.202 0.525 . . . . 0.0 111.191 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -102.36 -7.14 22.27 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.054 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.93 84.5 4.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.095 0.474 . . . . 0.0 110.139 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.051 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.65 -179.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' HG13 ' A' ' 5' ' ' ILE . 79.1 mtp . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 119.762 -0.161 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -50.31 -53.43 28.79 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -173.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -70.6 -42.92 70.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.077 0.465 . . . . 0.0 109.951 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.8 m -52.29 -41.13 62.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.483 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.592 ' O ' HG22 ' A' ' 8' ' ' ILE . 82.6 mt -62.64 -54.31 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.297 -176.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.425 ' HD2' ' N ' ' A' ' 7' ' ' GLU . 6.5 ppt_? -73.37 -22.75 60.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.877 0.37 . . . . 0.0 110.704 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.425 ' N ' ' HD2' ' A' ' 6' ' ' ARG . 44.0 tt0 -70.82 -36.28 72.86 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 -179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.3 tt -59.16 -32.11 47.39 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-O 120.699 0.285 . . . . 0.0 110.901 -176.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 6' ' ' ARG . 4.1 mm? -54.69 -27.01 37.22 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.32 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.21 -32.8 67.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.737 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.423 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 55.8 pttt -112.07 -14.74 13.39 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -173.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 8' ' ' ILE . 29.4 m-85 -124.01 -36.72 2.67 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.572 0.225 . . . . 0.0 111.289 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.76 120.33 10.91 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.897 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.6 52.83 1.23 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.534 0.683 . . . . 0.0 110.212 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.578 HD12 ' HD2' ' A' ' 16' ' ' PRO . 27.6 tp -77.28 124.8 87.04 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.28 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.578 ' HD2' HD12 ' A' ' 15' ' ' LEU . 41.4 Cg_endo -70.91 -17.0 32.67 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.329 2.019 . . . . 0.0 110.685 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.486 HG23 ' HD2' ' A' ' 18' ' ' PRO . 30.3 m -103.17 142.71 25.12 Favored Pre-proline 0 N--CA 1.44 -0.954 0 CA-C-N 114.185 -1.37 . . . . 0.0 109.836 -174.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 21' ' ' THR . 27.0 Cg_endo -62.16 126.62 19.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.49 2.127 . . . . 0.0 112.221 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.414 ' HA ' HG12 ' A' ' 22' ' ' ILE . 96.8 t -59.83 -19.1 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.318 0.58 . . . . 0.0 110.597 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -55.57 -28.61 55.99 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.961 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.614 HG22 ' O ' ' A' ' 18' ' ' PRO . 11.7 t -85.7 -27.77 25.09 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 111.56 0.207 . . . . 0.0 111.56 -176.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.494 HD12 HD22 ' A' ' 28' ' ' LEU . 31.9 pt -92.78 178.77 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.624 0.25 . . . . 0.0 110.717 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.99 176.79 5.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.38 -174.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -60.16 -31.44 70.11 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.143 0.497 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 38.9 mt-10 -103.7 14.71 30.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.568 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -112.69 143.78 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.25 . . . . 0.0 110.831 -178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -67.34 96.9 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.219 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD11 HD11 ' A' ' 66' ' ' ILE . 60.7 mt -54.21 -48.67 70.79 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.369 -177.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.521 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 25.0 p90 -63.23 -25.19 68.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.776 -177.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.18 -29.55 68.45 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.817 0.341 . . . . 0.0 110.883 -179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.43 -17.88 60.05 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.924 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.4 33.42 1.33 Allowed Glycine 0 C--N 1.33 0.22 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.532 178.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 49.5 tp -70.52 128.29 35.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.716 0.293 . . . . 0.0 110.426 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.3 m -94.99 149.12 21.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.212 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 39' ' ' VAL . 43.4 t -54.9 -49.08 72.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.067 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -64.56 -40.27 95.27 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.645 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.55 -31.85 68.35 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.428 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.569 ' HA ' HD23 ' A' ' 41' ' ' LEU . 19.1 m -75.98 -37.32 58.66 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.417 178.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.594 ' O ' ' HG2' ' A' ' 42' ' ' MET . 94.2 t -62.93 -48.75 86.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.126 177.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -58.34 -32.03 68.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.754 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -64.87 -43.75 91.95 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.392 -178.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 39' ' ' VAL . 22.9 ptp -73.01 -35.62 66.85 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.133 -0.227 . . . . 0.0 110.737 -175.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD22 ' HG3' ' A' ' 42' ' ' MET . 4.4 mm? -60.98 -47.19 87.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.63 0.253 . . . . 0.0 110.474 177.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.79 -41.12 89.37 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.712 -0.756 . . . . 0.0 111.732 178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 45' ' ' ILE . 1.5 mm -64.15 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 122.427 0.291 . . . . 0.0 111.25 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -56.55 -56.67 18.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.043 0.449 . . . . 0.0 110.342 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -71.7 -28.39 63.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.545 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.84 -49.27 66.08 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.376 -178.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -127.71 -33.62 2.27 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.412 ' OD2' HG23 ' A' ' 51' ' ' ILE . 34.7 t70 -179.78 -69.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.251 0.478 . . . . 0.0 111.901 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.55 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -139.1 175.91 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.765 0.316 . . . . 0.0 111.421 -177.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -108.6 169.2 8.8 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 177.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.646 ' HB3' HD11 ' A' ' 57' ' ' LEU . 75.0 m-85 -65.7 119.72 62.79 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.853 -174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.05 149.36 76.95 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.911 2.407 . . . . 0.0 111.901 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.427 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.3 p-10 -55.32 -24.45 28.98 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.98 -175.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.5 t-20 -54.83 -46.82 74.65 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.874 0.369 . . . . 0.0 110.72 178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.646 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -102.5 -14.12 16.95 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.753 -178.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 4.8 tt -64.21 92.03 0.08 Allowed 'General case' 0 C--O 1.234 0.247 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -161.32 156.47 23.97 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.793 -177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 60' ' ' ARG . 17.9 ptt-85 -48.63 -35.51 13.85 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.973 0.509 . . . . 0.0 111.237 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 6.2 tmtm? -53.79 -57.53 10.54 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.032 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.3 m -69.92 -43.69 71.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.473 -172.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.74 -9.5 54.72 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.742 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.64 -9.5 59.64 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.165 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -149.83 96.16 2.42 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.841 0.353 . . . . 0.0 110.794 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.523 ' HA ' HG22 ' A' ' 69' ' ' ILE . 46.6 mm -59.4 -44.25 92.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.294 -177.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -59.71 -27.46 66.47 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.17 -178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.84 -51.05 8.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.884 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.523 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.2 tt -62.19 -31.78 52.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.575 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.67 -35.8 66.38 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.665 0.269 . . . . 0.0 110.796 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.12 -39.06 79.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.049 0.452 . . . . 0.0 110.191 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.8 m -68.48 -37.28 79.99 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.163 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.5 HG23 HD12 ' A' ' 76' ' ' ILE . 12.3 p -75.34 -29.76 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.799 0.333 . . . . 0.0 110.445 177.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 mtpt -59.63 -32.87 70.84 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.561 175.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.1 mt -58.18 -31.78 67.62 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 73' ' ' VAL . 61.1 mt -66.08 -38.32 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.133 0 CA-C-O 121.168 0.508 . . . . 0.0 110.087 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 HD13 ' HD3' ' A' ' 80' ' ' LYS . 3.6 mm? -70.79 -28.52 64.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.345 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.85 -41.19 97.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.25 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.16 -49.08 2.7 Favored Glycine 0 CA--C 1.517 0.168 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.013 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.42 ' HD3' HD13 ' A' ' 77' ' ' LEU . 23.2 mmmt 58.93 -76.85 0.02 OUTLIER 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.22 1.008 . . . . 0.0 111.727 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -155.06 14.87 0.4 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.528 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.64 93.56 4.25 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.895 178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.085 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.099 178.947 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' O ' HG13 ' A' ' 5' ' ' ILE . 66.7 mtp . . . . . 0 N--CA 1.481 1.125 0 CA-C-O 119.761 -0.162 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -52.58 -48.12 66.44 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -175.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -75.61 -38.7 58.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.077 0.465 . . . . 0.0 110.104 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m -52.54 -48.96 65.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.866 178.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.647 ' O ' HG22 ' A' ' 8' ' ' ILE . 65.9 mt -59.8 -54.93 27.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 114.955 -1.021 . . . . 0.0 111.235 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 66' ' ' ILE . 4.0 ppt_? -67.03 -23.74 65.93 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.805 -0.358 . . . . 0.0 110.747 -178.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.76 -37.49 65.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.992 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.2 tt -61.09 -32.89 53.93 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.144 -179.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.603 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -59.33 -26.71 65.26 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.157 178.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.72 55.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.651 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 ptmm? -110.87 -53.43 2.7 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.619 ' HB3' HE22 ' A' ' 40' ' ' GLN . 4.3 m-85 -97.22 -21.31 17.35 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 122.366 -0.209 . . . . 0.0 111.527 -179.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -73.62 127.49 10.58 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.752 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -84.0 54.21 2.85 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.313 0.578 . . . . 0.0 110.241 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.546 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.3 tp -89.35 124.35 64.73 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' HD12 ' A' ' 15' ' ' LEU . 64.5 Cg_endo -74.5 -6.39 18.22 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.548 2.165 . . . . 0.0 111.646 -174.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' HB1' ' A' ' 31' ' ' ALA . 41.4 m -124.86 136.02 27.48 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.399 -176.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 21' ' ' THR . 27.9 Cg_endo -62.28 130.92 32.05 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.291 1.994 . . . . 0.0 111.984 -177.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -58.75 -25.4 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.189 0.519 . . . . 0.0 110.387 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -53.56 -28.51 32.22 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.247 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.608 HG22 ' O ' ' A' ' 18' ' ' PRO . 8.3 t -83.47 -29.53 27.93 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 121.185 -0.206 . . . . 0.0 111.445 -177.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.469 HG21 ' HB2' ' A' ' 31' ' ' ALA . 20.2 pt -96.55 177.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.52 0.2 . . . . 0.0 110.504 -177.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.429 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -158.03 175.04 14.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.737 0.303 . . . . 0.0 110.9 -176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -65.22 -32.74 74.57 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.0 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -85.89 8.41 20.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.121 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.429 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -116.1 166.57 11.86 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.494 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -87.91 105.95 17.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.875 178.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 22' ' ' ILE . 44.9 mt -55.89 -40.41 72.97 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.957 0.408 . . . . 0.0 111.373 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 48.2 p90 -64.71 -21.36 66.73 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.58 -177.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.29 -26.2 68.39 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.57 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -78.73 -14.52 59.24 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.495 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.45 39.36 1.94 Allowed Glycine 0 C--N 1.328 0.129 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.157 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 47.9 tp -78.24 105.99 9.85 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 40.9 t -99.02 166.13 11.42 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.65 -179.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 m -56.52 -38.14 71.42 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.798 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -55.19 -45.4 75.81 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.164 0.507 . . . . 0.0 110.587 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -74.25 -39.52 62.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.9 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.702 ' HA ' HD23 ' A' ' 41' ' ' LEU . 36.5 t -64.39 -55.44 21.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.18 -175.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.93 -41.26 85.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.036 0.446 . . . . 0.0 110.767 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.619 HE22 ' HB3' ' A' ' 12' ' ' PHE . 0.9 OUTLIER -64.61 -41.24 96.34 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 -176.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.702 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -60.95 -26.28 67.41 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.68 0.276 . . . . 0.0 110.43 -175.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.542 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 37.5 mtm -68.0 -39.52 83.22 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.225 -178.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -61.44 -42.73 99.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.616 -177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -75.32 -38.99 37.47 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.083 -0.579 . . . . 0.0 111.967 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.519 HG12 HG21 ' A' ' 8' ' ' ILE . 1.5 mm -67.55 -27.59 38.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-O 120.567 0.222 . . . . 0.0 111.108 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -53.22 -54.99 28.0 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.464 177.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -69.57 -29.86 67.51 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.484 -179.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.4 -49.89 63.56 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.306 -174.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.427 ' CE2' HG23 ' A' ' 45' ' ' ILE . 47.9 p90 -128.0 -34.39 2.14 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -179.02 -66.58 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.632 0.651 . . . . 0.0 112.034 -176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.62 174.45 12.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -175.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.25 169.47 8.49 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.08 178.154 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.549 ' HB3' HD11 ' A' ' 57' ' ' LEU . 60.4 m-85 -66.21 123.68 85.95 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.857 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -76.83 156.86 35.13 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.892 2.395 . . . . 0.0 112.389 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 58' ' ' LEU . 7.9 m-20 -50.97 -38.34 50.21 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.722 -176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -46.98 -44.6 20.28 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 123.582 0.551 . . . . 0.0 112.008 -176.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.549 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.3 pp -104.37 -12.75 16.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 110.864 -178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.542 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . 57.5 tp -67.82 -22.18 65.18 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.047 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -101.5 3.7 40.45 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.787 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -108.0 168.69 9.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.077 0.465 . . . . 0.0 111.492 -170.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -64.38 -16.72 62.83 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.405 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.7 m -39.96 -42.97 1.45 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.442 0.697 . . . . 0.0 112.698 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.503 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 16.9 m-85 -62.5 -31.56 72.33 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.83 -7.73 47.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.404 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.556 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 30.5 p -137.54 99.99 4.09 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.695 -177.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 69' ' ' ILE . 73.6 mt -55.9 -46.96 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.812 -176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.556 ' HE2' ' HB2' ' A' ' 65' ' ' SER . 0.0 OUTLIER -58.25 -29.68 65.96 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.585 0.231 . . . . 0.0 111.562 -178.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.71 -44.11 17.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.965 0.412 . . . . 0.0 110.981 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.5 tt -69.34 -35.94 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.704 -177.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.549 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.6 OUTLIER -68.09 -34.4 76.33 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 24.1 t70 -63.39 -46.35 86.85 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.537 178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.4 m -71.5 -39.27 70.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.56 -176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.483 HG23 HD12 ' A' ' 76' ' ' ILE . 14.5 p -65.99 -29.61 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.734 -178.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 71' ' ' ASP . 10.3 mtmp? -54.38 -43.98 71.85 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.205 0.526 . . . . 0.0 110.344 174.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 79.5 mt -60.71 -31.19 70.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.208 -0.906 . . . . 0.0 111.145 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.483 HD12 HG23 ' A' ' 73' ' ' VAL . 63.6 mt -63.86 -42.2 95.06 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 CA-C-O 121.159 0.504 . . . . 0.0 109.949 177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.414 ' HA ' ' HE3' ' A' ' 80' ' ' LYS . 3.9 mm? -67.82 -28.7 67.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.6 177.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -71.6 -22.47 61.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.919 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -159.34 69.86 0.25 Allowed Glycine 0 N--CA 1.452 -0.234 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 178.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' H ' ' HD2' ' A' ' 80' ' ' LYS . 9.2 mptt -56.49 -47.54 79.06 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.026 0.441 . . . . 0.0 111.032 -177.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -90.59 -26.33 19.73 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.473 -177.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -77.92 79.63 4.38 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.591 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.081 179.367 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 111.494 0.183 . . . . 0.0 111.494 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.807 ' HB3' ' HG2' ' A' ' 70' ' ' GLU . 3.5 p-10 -50.81 -55.94 14.5 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -171.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.36 98.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.939 0.399 . . . . 0.0 110.17 -178.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.9 m -56.89 -40.26 75.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.131 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 8' ' ' ILE . 96.2 mt -64.46 -60.19 3.09 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.272 -177.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.549 ' HA ' HD23 ' A' ' 9' ' ' LEU . 11.9 ptt180 -66.34 -23.16 66.31 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.998 -178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.73 -42.03 98.43 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.24 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 5' ' ' ILE . 5.3 tt -61.24 -31.59 50.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-O 120.826 0.346 . . . . 0.0 110.753 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.0 mm? -59.68 -25.1 64.48 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.058 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.27 -30.24 64.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.251 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' HE2' ' CE1' ' A' ' 12' ' ' PHE . 17.7 ptmt -105.14 -64.69 1.11 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -176.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.567 ' HB2' HG12 ' A' ' 8' ' ' ILE . 35.8 m-85 -79.87 -37.04 35.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.046 0.451 . . . . 0.0 110.63 -179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.568 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.31 132.77 30.45 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.988 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -83.24 52.0 2.1 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.043 0.449 . . . . 0.0 110.377 178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.571 HD12 ' HD2' ' A' ' 16' ' ' PRO . 30.8 tp -86.45 119.9 71.75 Favored Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.5 Cg_endo -75.38 -3.54 14.04 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.636 2.224 . . . . 0.0 111.656 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.0 m -119.41 139.06 27.18 Favored Pre-proline 0 N--CA 1.44 -0.955 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.638 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 21' ' ' THR . 29.2 Cg_endo -63.7 126.48 17.57 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.174 1.916 . . . . 0.0 111.698 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.9 t -60.22 -21.35 22.27 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-O 121.119 0.485 . . . . 0.0 110.926 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -57.81 -26.94 62.67 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.904 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.5 t -83.78 -19.42 35.11 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 120.612 0.244 . . . . 0.0 111.28 -177.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.723 HD12 ' HG ' ' A' ' 28' ' ' LEU . 29.2 pt -106.79 172.94 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -144.64 178.13 8.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.88 -176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -66.96 -33.2 75.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.963 -174.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.636 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 mt-10 -97.46 8.06 45.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.314 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.524 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -100.11 171.65 7.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.914 0.388 . . . . 0.0 110.854 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -86.65 87.19 7.39 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.202 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.723 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.2 mp -56.48 -39.2 72.81 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.773 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.5 p90 -69.09 -22.16 64.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.562 -177.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.19 -25.02 54.76 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.887 0.375 . . . . 0.0 110.708 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.3 -20.52 63.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.182 0.515 . . . . 0.0 110.204 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.95 39.21 0.71 Allowed Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.156 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 33.9 tp -73.34 126.81 30.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.468 -178.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -95.85 155.59 16.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.887 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 39' ' ' VAL . 20.9 p -53.91 -53.0 58.73 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.743 178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 40' ' ' GLN . 84.1 m-85 -53.96 -36.07 62.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.525 178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.54 -46.11 80.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.86 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.3 p -68.35 -26.77 65.76 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.162 -178.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 35' ' ' SER . 90.4 t -72.52 -49.91 38.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.774 0.321 . . . . 0.0 110.491 177.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 36' ' ' PHE . 13.2 mm100 -60.01 -31.49 69.99 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 121.176 0.513 . . . . 0.0 110.088 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.524 ' HA ' HD13 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -54.43 -37.04 64.67 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.749 177.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 39.6 mtm -68.52 -54.96 13.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.799 0.333 . . . . 0.0 111.14 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 43' ' ' LEU . 3.4 mm? -59.7 -47.89 83.84 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.454 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.547 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.15 -34.1 85.13 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 120.713 -0.755 . . . . 0.0 112.249 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.496 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.8 mm -69.97 -30.8 45.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 120.555 0.217 . . . . 0.0 110.797 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 35.6 tt0 -56.77 -55.33 35.65 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.233 0.54 . . . . 0.0 109.806 176.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -70.49 -27.56 64.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.734 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.66 -50.43 72.13 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.8 p90 -128.91 -33.61 1.99 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 51' ' ' ILE . 13.1 t70 -177.24 -69.61 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 118.776 0.716 . . . . 0.0 112.459 -178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.543 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -133.62 168.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.074 0.464 . . . . 0.0 111.393 -178.015 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -99.63 168.64 9.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.362 175.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.621 ' HB3' HD11 ' A' ' 57' ' ' LEU . 51.2 m-85 -61.09 125.03 82.87 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.619 -175.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.61 156.86 53.33 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.785 2.324 . . . . 0.0 112.253 177.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.489 ' HA ' HD12 ' A' ' 58' ' ' LEU . 6.0 m-20 -51.22 -37.42 46.71 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.762 -0.653 . . . . 0.0 111.502 -176.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -46.08 -41.24 11.97 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.465 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.621 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.2 pp -116.58 11.01 14.62 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -172.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 55' ' ' ASP . 45.5 mt -67.25 -3.22 7.28 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.445 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.1 OUTLIER -58.09 140.41 52.71 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 172.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -15.7 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.712 0.292 . . . . 0.0 111.392 -172.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.0 tmtm? -58.33 -46.01 87.02 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.187 177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 47.7 m -70.43 -38.8 74.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.814 -177.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -64.72 -18.4 64.98 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.138 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -80.96 1.01 32.95 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.349 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.1 p -154.1 91.76 1.47 Allowed 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.369 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.464 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.8 mm -58.86 -44.96 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.036 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.636 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -58.06 -27.68 63.83 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.791 0.329 . . . . 0.0 111.432 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.63 -52.32 7.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.878 0.37 . . . . 0.0 110.737 -179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.464 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.1 tt -62.79 -32.63 56.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.006 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.807 ' HG2' ' HB3' ' A' ' 2' ' ' ASN . 0.5 OUTLIER -68.97 -28.22 66.42 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.246 0.546 . . . . 0.0 110.298 179.124 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.557 ' HA ' ' NZ ' ' A' ' 74' ' ' LYS . 26.2 t70 -72.16 -33.76 67.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.027 0.441 . . . . 0.0 109.873 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.2 m -70.81 -34.45 71.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.27 -178.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.672 HG12 ' O ' ' A' ' 70' ' ' GLU . 9.8 p -64.37 -28.17 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.665 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' NZ ' ' HA ' ' A' ' 71' ' ' ASP . 60.2 mttp -51.8 -49.05 63.5 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 121.42 0.628 . . . . 0.0 110.101 175.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 81.4 mt -52.81 -30.95 36.16 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.554 -177.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.529 HD12 HG23 ' A' ' 73' ' ' VAL . 55.2 mt -67.93 -38.75 80.53 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 CA-C-O 121.005 0.431 . . . . 0.0 110.1 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.0 mt -76.68 -32.25 57.79 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.341 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -69.99 -37.37 75.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 109.969 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.79 37.37 3.74 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.076 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 37.1 mmtt -42.82 -65.17 0.51 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 122.902 0.481 . . . . 0.0 111.692 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -118.53 26.94 9.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.477 0.656 . . . . 0.0 109.536 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -87.67 12.86 11.64 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.72 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.143 0 CA-C-O 118.812 -0.614 . . . . 0.0 110.044 178.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 65.4 mtp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 119.611 -0.233 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.423 ' OD1' ' N ' ' A' ' 3' ' ' ALA . 27.9 p30 -59.07 -41.5 88.13 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 118.144 0.429 . . . . 0.0 111.319 -175.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' N ' ' OD1' ' A' ' 2' ' ' ASN . . . -71.3 -41.12 70.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.4 m -54.46 -44.62 72.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.159 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 8' ' ' ILE . 73.1 mt -66.83 -48.4 79.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.005 -176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -69.06 -28.26 66.38 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.034 0.445 . . . . 0.0 110.215 179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -65.79 -42.95 90.14 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.033 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 12' ' ' PHE . 10.9 tt -61.78 -31.81 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.191 -175.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.4 mm? -58.99 -31.11 68.49 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.647 -0.251 . . . . 0.0 111.511 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.71 -30.43 65.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.789 0.328 . . . . 0.0 111.345 -177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -107.8 -56.34 2.24 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.952 -173.208 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.621 ' HD2' HE22 ' A' ' 40' ' ' GLN . 26.8 m-85 -84.71 -36.71 21.66 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.845 0.355 . . . . 0.0 110.903 179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.22 126.1 41.05 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.48 -176.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -85.66 42.35 0.96 Allowed 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.269 0.557 . . . . 0.0 110.224 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.07 130.59 84.64 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.77 -17.61 22.78 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.155 1.903 . . . . 0.0 111.275 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 HG23 ' HD2' ' A' ' 18' ' ' PRO . 23.3 m -110.8 141.1 23.42 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.426 -178.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.581 ' O ' HG22 ' A' ' 21' ' ' THR . 21.7 Cg_endo -61.75 124.39 14.47 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.246 1.964 . . . . 0.0 111.683 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.54 -21.61 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-O 121.288 0.566 . . . . 0.0 110.442 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -53.3 -33.91 55.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.057 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.9 t -82.81 -23.01 33.99 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.558 0.218 . . . . 0.0 111.535 -175.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.53 HG21 ' HB2' ' A' ' 31' ' ' ALA . 36.3 pt -104.24 -177.28 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 121.026 0.441 . . . . 0.0 110.783 -178.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.457 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -164.07 176.29 9.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.616 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.418 ' CB ' ' HB ' ' A' ' 66' ' ' ILE . 15.7 p-10 -62.15 -36.41 81.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.084 0.468 . . . . 0.0 110.553 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -80.1 -0.73 37.04 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.902 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.457 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -108.23 154.55 21.6 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.963 0.411 . . . . 0.0 111.121 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -73.23 100.29 3.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.532 0.682 . . . . 0.0 110.486 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.537 HD11 HG13 ' A' ' 66' ' ' ILE . 62.9 mt -61.39 -24.87 66.8 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.991 -174.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.497 ' OH ' ' HB1' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -58.49 -34.03 70.45 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.197 0.522 . . . . 0.0 109.653 -178.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.1 -29.0 69.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.327 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.53 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -85.95 -8.96 57.64 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.87 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.14 43.55 4.66 Favored Glycine 0 N--CA 1.453 -0.223 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.674 177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 57.3 tp -59.37 107.02 0.51 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.88 0.372 . . . . 0.0 110.2 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.0 m -104.07 158.12 16.65 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.782 -177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.1 t -56.45 -55.14 37.4 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.448 -174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' HA ' HG22 ' A' ' 39' ' ' VAL . 85.4 t80 -55.65 -41.6 73.84 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-O 120.844 0.354 . . . . 0.0 110.546 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.66 94.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.733 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.682 ' HA ' HD23 ' A' ' 41' ' ' LEU . 33.3 p -76.69 -31.06 56.99 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.909 -177.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 36' ' ' PHE . 26.9 m -84.27 -33.85 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 122.135 -0.353 . . . . 0.0 111.183 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.621 HE22 ' HD2' ' A' ' 12' ' ' PHE . 21.2 tm0? -66.99 -38.61 86.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.325 -177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.7 pp -56.6 -28.56 60.66 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 121.011 0.434 . . . . 0.0 110.484 -178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.543 ' HB3' ' HB2' ' A' ' 52' ' ' GLU . 44.2 mtm -68.9 -37.78 79.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.617 -176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 69.9 mt -59.18 -45.36 91.24 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.568 -177.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -77.08 -29.84 56.24 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.002 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -71.86 -28.5 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 122.264 0.226 . . . . 0.0 111.259 -178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -55.31 -55.89 26.36 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.237 0.542 . . . . 0.0 110.618 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -67.77 -29.09 68.21 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.803 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.74 -49.26 71.23 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -175.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 45' ' ' ILE . 53.6 p90 -128.32 -32.6 2.21 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' OD2' HG23 ' A' ' 51' ' ' ILE . 16.6 t70 -179.48 -70.34 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 118.323 0.51 . . . . 0.0 112.06 -177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.579 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.03 170.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.842 0.353 . . . . 0.0 111.027 -176.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 42' ' ' MET . 0.0 OUTLIER -106.15 167.88 9.52 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.398 174.025 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB3' HD11 ' A' ' 57' ' ' LEU . 40.5 m-85 -65.84 133.23 94.92 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.53 -171.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.471 ' HD2' HD21 ' A' ' 57' ' ' LEU . 84.2 Cg_endo -77.7 154.81 30.85 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.091 2.527 . . . . 0.0 112.11 -178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -57.45 -34.08 68.61 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.231 -172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.0 m-80 -57.32 -18.56 17.52 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -176.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.883 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -120.88 0.52 10.31 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.635 178.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 77.4 mt -75.52 155.48 36.06 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 64.63 12.87 7.88 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.369 0.418 . . . . 0.0 111.019 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 60' ' ' ARG . 23.2 ttt180 -114.63 173.43 6.47 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.485 -173.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -56.3 -8.93 0.57 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -177.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 35.0 p -53.36 -55.0 28.51 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.854 0.359 . . . . 0.0 110.956 177.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -69.0 -19.44 64.14 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.304 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.497 ' HB1' ' OH ' ' A' ' 29' ' ' TYR . . . -70.23 -18.84 63.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.127 0.489 . . . . 0.0 110.839 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.429 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 47.8 m -149.45 105.77 3.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.015 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.537 HG13 HD11 ' A' ' 28' ' ' LEU . 66.8 mt -54.16 -43.72 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.669 -175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -59.34 -27.48 65.96 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.735 0.302 . . . . 0.0 111.535 179.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -76.32 -46.47 27.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.601 179.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 66' ' ' ILE . 18.2 tt -72.78 -32.93 42.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.554 -176.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.461 ' O ' HG12 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -64.84 -30.39 71.38 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.065 0.459 . . . . 0.0 110.042 -179.366 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -69.62 -37.43 76.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.056 176.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.607 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 19.9 m -75.99 -31.82 59.16 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.847 -177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 70' ' ' GLU . 12.2 p -69.89 -29.0 38.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 O-C-N 121.804 -0.56 . . . . 0.0 110.409 179.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 91.3 mttt -60.25 -47.61 85.27 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.387 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 72' ' ' THR . 4.4 pp -61.12 -28.8 69.36 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.583 0.23 . . . . 0.0 110.612 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.485 ' N ' HD12 ' A' ' 75' ' ' LEU . 64.3 mt -62.37 -51.04 77.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 80' ' ' LYS . 4.6 mm? -56.86 -27.03 59.8 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.203 178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -67.73 -21.48 65.29 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.769 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -171.7 57.88 0.17 Allowed Glycine 0 CA--C 1.516 0.152 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.051 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.521 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 2.7 mppt? -45.35 -68.56 0.19 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.29 0.567 . . . . 0.0 111.905 -174.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.2 -12.94 18.35 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.97 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.32 80.69 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.021 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.732 -0.652 . . . . 0.0 110.487 -178.327 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.4 mtp . . . . . 0 N--CA 1.484 1.226 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -52.5 -49.78 64.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.784 0.326 . . . . 0.0 111.639 -175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -71.93 -40.11 68.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.06 0.457 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 m -52.39 -44.23 65.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.744 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 8' ' ' ILE . 64.1 mt -68.81 -58.71 4.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.203 -177.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.0 ptp85 -58.4 -30.29 66.73 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 121.178 0.514 . . . . 0.0 110.456 -177.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -70.54 -40.13 73.6 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.538 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.645 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.9 tt -60.9 -31.6 50.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.808 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.42 -29.63 25.37 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.306 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.11 -38.79 66.22 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.667 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HG3' ' HD2' ' A' ' 12' ' ' PHE . 0.0 OUTLIER -105.83 -15.93 14.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -170.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.57 ' HB2' HG12 ' A' ' 8' ' ' ILE . 52.2 m-85 -127.64 -36.0 2.08 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 120.726 0.298 . . . . 0.0 111.02 178.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.96 111.45 3.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.013 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -76.69 67.52 2.81 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.578 0.704 . . . . 0.0 110.097 178.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.557 HD12 ' HD2' ' A' ' 16' ' ' PRO . 24.6 tp -94.99 131.15 30.82 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.352 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.557 ' HD2' HD12 ' A' ' 15' ' ' LEU . 58.6 Cg_endo -73.42 -15.5 24.93 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.356 2.037 . . . . 0.0 111.187 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.483 HG23 ' HD2' ' A' ' 18' ' ' PRO . 21.1 m -109.56 141.89 24.57 Favored Pre-proline 0 N--CA 1.443 -0.798 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.632 -177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' O ' ' HB ' ' A' ' 21' ' ' THR . 14.2 Cg_endo -58.34 128.85 30.08 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.286 1.991 . . . . 0.0 112.068 -178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.535 HG13 HD11 ' A' ' 22' ' ' ILE . 37.3 t -70.11 -6.84 7.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.242 0.544 . . . . 0.0 111.111 -178.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -85.77 -20.88 28.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.969 0.89 . . . . 0.0 108.828 178.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 18' ' ' PRO . 1.3 m -76.54 -25.28 53.94 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 114.105 -1.407 . . . . 0.0 110.906 177.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 28' ' ' LEU . 22.7 pt -100.02 179.87 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.098 176.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.463 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -156.21 171.91 19.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.516 -177.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.584 ' HA ' HD12 ' A' ' 66' ' ' ILE . 15.2 t70 -55.76 -44.13 77.35 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.623 -175.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.564 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 28.6 mt-10 -95.81 7.29 46.73 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.911 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.463 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -87.65 173.77 8.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 111.045 -177.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -87.28 92.38 9.05 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.487 0.661 . . . . 0.0 110.666 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 28' ' ' LEU . 2.1 mm? -61.49 -48.94 78.79 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.671 -174.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 15.7 p90 -55.99 -36.66 68.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.666 -178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.29 -28.65 67.37 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.386 -176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -67.75 -20.8 65.28 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.135 0.493 . . . . 0.0 110.485 177.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.99 26.28 2.8 Favored Glycine 0 N--CA 1.454 -0.138 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.289 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 55.6 tp -61.11 105.86 0.53 Allowed 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 14.6 m -95.55 163.55 13.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.272 -177.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 m -55.91 -40.07 72.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.976 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.98 -50.66 72.47 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.583 179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.37 -38.51 80.65 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.867 178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.524 ' HA ' HD23 ' A' ' 41' ' ' LEU . 32.4 t -65.46 -55.79 16.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.523 -178.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.72 -28.76 45.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.963 0.411 . . . . 0.0 110.592 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -66.14 -43.26 87.57 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.693 -179.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -66.19 -27.99 68.42 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -178.729 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.644 ' SD ' ' HD2' ' A' ' 53' ' ' PHE . 20.4 mmt -63.83 -43.83 95.02 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.386 179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.3 mt -55.75 -48.54 75.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.739 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.427 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -75.17 -40.44 34.32 Favored Glycine 0 CA--C 1.52 0.365 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.391 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -64.2 -29.09 46.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-O 120.558 0.218 . . . . 0.0 111.157 -178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -55.49 -56.63 17.96 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.178 0.513 . . . . 0.0 110.316 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.34 -28.8 63.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.599 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.78 -50.23 63.99 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -174.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 45' ' ' ILE . 45.4 p90 -128.2 -33.63 2.15 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -177.63 -69.13 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 118.306 0.503 . . . . 0.0 111.256 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -137.8 177.04 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.481 -179.257 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 167.98 9.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.768 178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.742 ' HB3' HD11 ' A' ' 57' ' ' LEU . 89.0 m-85 -61.57 122.88 73.98 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.185 -178.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.16 158.52 54.67 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.842 2.362 . . . . 0.0 113.14 -176.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -57.78 -22.17 45.7 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.199 -0.909 . . . . 0.0 111.623 -178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.28 -39.69 93.77 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.319 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.742 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -109.4 -10.84 14.89 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.623 0.249 . . . . 0.0 110.962 -178.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -38.47 67.31 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.231 0.539 . . . . 0.0 110.41 -177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -103.21 32.58 3.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.235 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 60' ' ' ARG . 1.0 OUTLIER -122.22 165.13 16.65 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.242 0.544 . . . . 0.0 111.707 -175.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.505 ' H ' ' HG3' ' A' ' 60' ' ' ARG . 63.0 pttt -62.51 -6.94 3.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.031 0.932 . . . . 0.0 112.78 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 m -47.88 -31.93 5.66 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.896 0.379 . . . . 0.0 111.751 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -74.32 2.16 9.92 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 -18.44 43.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.775 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.409 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.1 m -151.28 117.6 5.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.295 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.584 HD12 ' HA ' ' A' ' 24' ' ' ASP . 44.9 mt -62.15 -48.74 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.98 -0.1 . . . . 0.0 111.252 -175.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.564 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.8 OUTLIER -54.19 -27.97 37.59 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.924 0.393 . . . . 0.0 111.196 177.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.31 -45.95 18.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.1 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.526 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.3 tt -72.09 -36.53 57.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.33 -176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.51 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.9 pp20? -65.94 -30.17 70.71 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.386 -178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.604 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 21.9 t70 -68.58 -31.11 70.08 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.195 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 21.9 m -74.75 -38.95 62.09 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.055 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.554 HG23 HD12 ' A' ' 76' ' ' ILE . 11.8 p -68.91 -29.78 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.828 -0.349 . . . . 0.0 110.321 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.604 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 41.4 mtpt -57.61 -34.73 69.59 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.911 0.386 . . . . 0.0 110.565 173.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 70.7 mt -60.27 -29.63 68.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.554 HD12 HG23 ' A' ' 73' ' ' VAL . 55.7 mt -66.11 -33.25 62.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.139 177.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 77' ' ' LEU . 3.5 mm? -76.98 -29.87 55.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.137 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -64.22 -48.01 77.48 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.176 0.512 . . . . 0.0 109.63 173.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -102.67 65.78 0.39 Allowed Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.648 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.55 ' HA ' ' HE2' ' A' ' 80' ' ' LYS . 6.2 mmpt? -65.09 -64.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.073 0.463 . . . . 0.0 110.725 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -70.29 -31.2 68.44 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.403 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.42 82.16 8.42 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.452 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 118.427 -0.797 . . . . 0.0 110.282 -177.827 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' O ' HG13 ' A' ' 5' ' ' ILE . 58.5 mtp . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 119.792 -0.147 . . . . 0.0 111.341 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -54.14 -45.85 72.1 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.809 0.338 . . . . 0.0 111.699 -174.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.63 -36.98 57.08 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.4 m -54.38 -42.83 70.83 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.934 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 8' ' ' ILE . 77.8 mt -64.44 -45.12 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.546 -176.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -73.54 -29.88 62.73 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.175 0.512 . . . . 0.0 109.863 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -63.58 -41.73 98.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.061 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.587 HG12 ' HB2' ' A' ' 12' ' ' PHE . 15.2 tt -60.97 -31.33 49.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.457 -174.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -55.32 -26.31 39.96 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.773 0.32 . . . . 0.0 111.167 178.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.68 55.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -102.84 -19.66 14.59 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.587 ' HB2' HG12 ' A' ' 8' ' ' ILE . 37.1 m-85 -128.89 -36.44 1.8 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.693 0.282 . . . . 0.0 111.577 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.28 120.82 20.97 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.464 -177.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.53 63.92 4.26 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.501 0.667 . . . . 0.0 110.568 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.539 HD12 ' HD2' ' A' ' 16' ' ' PRO . 26.9 tp -95.17 129.95 33.91 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.529 -0.759 . . . . 0.0 109.524 177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' A' ' 15' ' ' LEU . 75.6 Cg_endo -77.92 2.62 7.73 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.632 2.221 . . . . 0.0 112.168 -178.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.51 HG23 ' HD2' ' A' ' 18' ' ' PRO . 4.9 m -129.73 143.19 48.01 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.721 -176.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.575 ' O ' HG22 ' A' ' 21' ' ' THR . 19.4 Cg_endo -58.97 121.54 10.11 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.493 2.129 . . . . 0.0 112.01 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 48.8 t -59.95 -18.53 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 121.341 0.591 . . . . 0.0 110.795 -178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.81 -31.37 59.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.855 177.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.3 t -82.15 -26.21 33.66 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 111.548 0.203 . . . . 0.0 111.548 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 21' ' ' THR . 36.8 pt -100.43 169.34 1.69 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-O 120.911 0.386 . . . . 0.0 110.904 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.466 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -169.53 -174.13 1.84 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.031 -174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 15.9 p-10 -62.17 -36.18 81.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.089 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -89.01 0.22 56.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.854 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -115.93 141.28 48.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.822 0.344 . . . . 0.0 110.702 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -66.08 100.41 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.56 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 HD11 HD11 ' A' ' 66' ' ' ILE . 59.4 mt -52.62 -48.32 66.42 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.235 0.541 . . . . 0.0 111.198 -178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 17.4 p90 -63.55 -21.88 66.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.929 -177.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.03 -23.82 65.94 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.924 0.392 . . . . 0.0 110.667 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -82.84 -5.9 59.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.76 176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.52 37.5 3.99 Favored Glycine 0 C--N 1.328 0.133 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.311 178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 57.9 tp -74.39 121.93 22.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.666 0.269 . . . . 0.0 110.335 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 59.3 p -95.78 152.96 18.0 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.009 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.0 m -58.33 -26.75 63.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.9 0.381 . . . . 0.0 110.249 177.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -64.91 -47.6 77.19 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.026 175.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.67 69.91 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.41 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.632 ' HA ' HD23 ' A' ' 41' ' ' LEU . 34.3 t -69.55 -52.25 27.98 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.852 -178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 11.8 p -61.77 -37.22 77.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.996 0.427 . . . . 0.0 110.772 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -64.69 -36.61 84.84 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.018 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.632 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.7 OUTLIER -62.76 -30.51 71.5 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -178.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.2 mtm -74.45 -43.17 57.35 Favored 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 tp -53.16 -49.57 66.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.817 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -74.3 -36.59 49.95 Favored Glycine 0 C--N 1.331 0.271 0 CA-C-N 115.843 -0.617 . . . . 0.0 112.24 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -63.81 -28.67 45.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.618 0.247 . . . . 0.0 111.011 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.68 -56.43 21.46 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.623 178.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -71.55 -28.7 64.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.283 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.45 -49.16 65.16 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.803 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 45' ' ' ILE . 46.0 p90 -128.62 -34.23 2.01 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.476 ' OD2' HG23 ' A' ' 51' ' ' ILE . 11.4 t70 -178.62 -65.26 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 118.905 0.775 . . . . 0.0 112.552 -176.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.562 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.26 171.71 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 CA-C-O 120.834 0.35 . . . . 0.0 111.332 -175.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.1 168.84 9.0 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.288 173.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' HB3' HD11 ' A' ' 57' ' ' LEU . 63.3 m-85 -64.9 116.45 29.75 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.632 -173.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.85 155.26 66.09 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.152 2.568 . . . . 0.0 112.577 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -53.34 -33.99 55.72 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -52.41 -35.99 53.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.67 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -118.44 -1.54 11.22 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.659 0.266 . . . . 0.0 110.951 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 35.4 tp -63.3 89.74 0.04 OUTLIER 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.058 0.456 . . . . 0.0 109.853 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 45.9 t-20 -156.88 145.69 19.99 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -177.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.401 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 66.7 mtm180 -50.19 -35.59 26.99 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.477 0.485 . . . . 0.0 110.571 179.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 61' ' ' LYS . 1.4 tpmt? -53.04 -44.32 67.29 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 19.5 m -70.22 -47.03 63.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -66.39 -29.33 69.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.951 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.63 -20.63 66.38 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.049 0.452 . . . . 0.0 110.837 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.0 m -128.72 78.76 1.87 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.463 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.605 ' HA ' HG22 ' A' ' 69' ' ' ILE . 64.1 mt -54.68 -43.02 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.478 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.522 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.7 OUTLIER -53.49 -32.89 52.22 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.741 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.69 -51.87 7.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.14 0.495 . . . . 0.0 110.822 179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.605 HG22 ' HA ' ' A' ' 66' ' ' ILE . 11.8 tt -61.23 -31.3 49.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.255 -174.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.68 -30.68 71.75 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.937 -177.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.545 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 36.5 t70 -81.39 -36.22 29.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.922 0.391 . . . . 0.0 110.048 177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.6 m -62.02 -40.19 94.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.507 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.433 ' HA ' HD12 ' A' ' 76' ' ' ILE . 14.8 p -69.65 -29.84 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 178.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 9.1 mtpm? -60.32 -42.89 96.52 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 172.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.7 mt -59.62 -34.01 72.22 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.982 176.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 73' ' ' VAL . 68.2 mt -64.95 -49.35 80.2 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.499 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.105 176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.05 -29.41 65.35 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 111.364 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -72.57 -31.6 65.36 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.662 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.88 71.32 0.28 Allowed Glycine 0 N--CA 1.453 -0.226 0 N-CA-C 111.454 -0.659 . . . . 0.0 111.454 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.481 ' HD3' ' H ' ' A' ' 80' ' ' LYS . 3.2 mppt? -58.69 -42.39 88.44 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.35 0.595 . . . . 0.0 110.47 -178.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -78.57 55.32 1.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.147 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -99.63 21.11 12.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.547 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.692 -0.671 . . . . 0.0 110.237 -179.753 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.437 ' O ' HG13 ' A' ' 5' ' ' ILE . 64.1 mtp . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 111.695 0.258 . . . . 0.0 111.695 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 31.3 p-10 -54.34 -42.33 70.1 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 111.832 0.308 . . . . 0.0 111.832 -172.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.52 36.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.125 0.488 . . . . 0.0 110.196 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 m -53.6 -45.38 70.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.396 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.663 HD13 ' HZ ' ' A' ' 53' ' ' PHE . 64.3 mt -61.5 -44.5 98.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.641 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -74.83 -28.79 60.83 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.025 0.44 . . . . 0.0 110.404 176.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -63.62 -36.7 84.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.279 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.6 tt -65.23 -32.74 59.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 121.162 -0.215 . . . . 0.0 111.449 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD21 HD22 ' A' ' 41' ' ' LEU . 4.3 mm? -58.94 -26.72 64.65 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.651 0.263 . . . . 0.0 111.279 -178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.88 -29.32 66.5 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.328 -179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.421 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 36.3 pttt -111.02 -55.01 2.55 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.565 ' HB2' HG12 ' A' ' 8' ' ' ILE . 68.6 m-85 -87.73 -25.47 23.42 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 120.697 0.284 . . . . 0.0 111.514 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.27 124.53 7.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.641 -175.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -82.31 64.85 7.17 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.309 0.576 . . . . 0.0 110.2 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HD23 ' A' ' 33' ' ' LEU . 25.8 tp -96.99 130.87 28.89 Favored Pre-proline 0 CA--C 1.534 0.332 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.396 178.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.55 ' HD2' HD12 ' A' ' 15' ' ' LEU . 68.4 Cg_endo -76.94 -11.45 18.04 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.626 2.217 . . . . 0.0 112.001 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 HG23 ' HD2' ' A' ' 18' ' ' PRO . 27.2 m -115.37 142.99 29.57 Favored Pre-proline 0 N--CA 1.442 -0.865 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.633 -176.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 Cg_endo -59.8 123.62 13.64 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.271 1.981 . . . . 0.0 111.893 178.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG13 HD11 ' A' ' 22' ' ' ILE . 23.9 t -66.56 -14.24 17.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.352 0.596 . . . . 0.0 110.322 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.85 -29.72 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.755 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.611 HG22 ' O ' ' A' ' 18' ' ' PRO . 13.8 t -81.5 -33.62 31.77 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.71 0.29 . . . . 0.0 111.427 -175.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.536 HG21 ' HB2' ' A' ' 31' ' ' ALA . 18.7 pt -82.39 175.7 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.606 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -167.54 176.27 6.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.266 -178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -66.63 -29.41 69.44 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.568 -177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -90.38 7.48 38.39 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.157 175.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.527 ' O ' HD22 ' A' ' 28' ' ' LEU . . . -117.11 162.08 18.39 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.01 94.7 2.9 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 178.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD22 ' O ' ' A' ' 26' ' ' ALA . 3.2 mm? -54.83 -49.29 71.41 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.182 0.515 . . . . 0.0 110.859 -178.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 33' ' ' LEU . 48.2 p90 -62.36 -24.8 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.698 -175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -66.04 -23.0 66.46 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 111.163 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' HB2' HG21 ' A' ' 22' ' ' ILE . . . -69.0 -13.88 62.71 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.269 0.557 . . . . 0.0 110.63 176.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 108.49 32.56 3.14 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.476 177.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.566 HD23 HD13 ' A' ' 15' ' ' LEU . 32.7 mt -60.29 106.47 0.53 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.956 0.408 . . . . 0.0 109.915 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.6 m -95.88 169.03 10.28 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.811 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -57.51 -44.22 84.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.993 -175.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -58.22 -51.09 71.2 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.108 -179.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.77 -39.24 70.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.743 ' HA ' HD23 ' A' ' 41' ' ' LEU . 22.0 m -72.17 -51.82 19.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.366 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.2 m -64.91 -31.13 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.145 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -72.26 -41.06 67.17 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.647 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.743 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -61.16 -27.32 68.31 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.421 ' HE2' ' HG ' ' A' ' 41' ' ' LEU . 21.5 mmt -57.93 -56.51 21.08 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.752 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.3 mp -60.13 -36.91 78.56 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.423 -173.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -77.99 -35.66 34.24 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.035 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.534 HG12 HG21 ' A' ' 8' ' ' ILE . 0.6 OUTLIER -70.89 -28.13 32.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.647 0.261 . . . . 0.0 110.914 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' HB2' ' HG3' ' A' ' 52' ' ' GLU . 41.9 tt0 -55.86 -54.37 45.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.011 175.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -70.49 -30.61 67.44 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.737 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.77 -49.89 71.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.496 ' CE2' HG23 ' A' ' 45' ' ' ILE . 49.8 p90 -128.14 -33.57 2.17 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -179.69 -66.67 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 118.116 0.416 . . . . 0.0 111.889 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.04 172.72 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.829 0.347 . . . . 0.0 110.762 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.482 ' HG3' ' HB2' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -104.7 168.71 8.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.138 175.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.663 ' HZ ' HD13 ' A' ' 5' ' ' ILE . 51.2 m-85 -70.12 124.77 91.37 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.15 -176.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.46 156.24 58.57 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.101 2.534 . . . . 0.0 112.393 -175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -55.46 -29.01 57.9 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.104 -176.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -57.43 -31.48 65.93 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.997 -177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.5 pp -121.02 -1.26 9.86 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.644 0.259 . . . . 0.0 111.1 -178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 tt -67.5 86.25 0.19 Allowed 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.306 0.574 . . . . 0.0 109.537 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 31.2 p30 -151.59 157.15 41.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.123 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -58.64 -27.71 64.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' HE2' ' A' ' 61' ' ' LYS . 8.9 mmpt? -56.56 -54.41 46.22 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.577 0.703 . . . . 0.0 109.979 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.1 m -64.02 -48.92 74.45 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.072 -177.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -64.91 -19.39 65.9 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.662 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.26 -23.18 63.81 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.693 0.282 . . . . 0.0 111.067 177.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.426 ' HB2' ' HE2' ' A' ' 67' ' ' LYS . 18.3 p -134.26 90.54 2.69 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.089 0.471 . . . . 0.0 110.774 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.463 ' HA ' HG22 ' A' ' 69' ' ' ILE . 39.8 mm -53.29 -45.72 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.581 -177.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.449 ' HD3' ' H ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.53 -29.55 67.97 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 120.729 0.3 . . . . 0.0 111.306 -177.588 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.49 -45.43 15.99 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.091 0.472 . . . . 0.0 110.77 -178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.463 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.7 tt -68.76 -34.23 63.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.057 -176.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.497 ' HA ' HG12 ' A' ' 73' ' ' VAL . 2.5 pp20? -72.47 -33.84 67.3 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.891 0.377 . . . . 0.0 110.017 178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 19.5 t70 -61.48 -33.82 74.41 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.431 0.634 . . . . 0.0 109.833 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 m -72.01 -43.58 64.81 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.008 -179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.497 HG12 ' HA ' ' A' ' 70' ' ' GLU . 11.6 p -65.87 -28.36 43.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-O 120.592 0.234 . . . . 0.0 110.668 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.561 ' HD3' ' HA ' ' A' ' 71' ' ' ASP . 28.4 mtpp -55.9 -39.08 71.08 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 120.989 0.423 . . . . 0.0 110.141 173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.2 mt -66.63 -38.71 87.48 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.17 178.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 73' ' ' VAL . 69.6 mt -57.62 -50.2 78.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.762 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 80' ' ' LYS . 97.4 mt -58.68 -30.71 67.57 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.207 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -68.66 -43.81 75.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.779 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 83' ' ' ALA . . . -103.36 46.93 1.15 Allowed Glycine 0 CA--C 1.517 0.177 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.015 -176.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 77' ' ' LEU . 39.8 mtmt -91.22 -63.53 1.25 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.393 0.616 . . . . 0.0 111.265 178.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.72 -14.59 63.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.701 -169.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -112.39 14.83 20.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.234 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 79' ' ' GLY . . . . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.532 -0.747 . . . . 0.0 110.838 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.475 ' O ' HG13 ' A' ' 5' ' ' ILE . 52.6 mtp . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -56.47 -43.93 80.09 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.655 0.264 . . . . 0.0 111.321 -173.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 6' ' ' ARG . . . -66.75 -45.27 79.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.105 0.479 . . . . 0.0 110.031 177.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.0 m -53.25 -40.38 64.55 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.159 175.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.611 ' O ' HG22 ' A' ' 8' ' ' ILE . 91.6 mt -70.88 -50.98 39.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.949 -177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 3' ' ' ALA . 8.3 ptm180 -64.92 -26.58 68.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.122 0.487 . . . . 0.0 109.926 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -76.2 -39.34 54.95 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.844 -0.617 . . . . 0.0 112.041 -178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.635 HG12 ' HB2' ' A' ' 12' ' ' PHE . 7.2 tt -58.54 -32.95 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.051 -174.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.52 -28.33 63.38 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.801 0.334 . . . . 0.0 111.006 178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.71 -37.41 49.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.521 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.9 ptmm? -104.83 -14.86 15.37 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.635 ' HB2' HG12 ' A' ' 8' ' ' ILE . 40.5 m-85 -127.88 -36.86 1.97 Allowed 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.709 0.29 . . . . 0.0 110.951 177.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.51 124.81 22.43 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.782 -175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.402 ' H ' ' HA ' ' A' ' 37' ' ' ALA . 54.6 tp60 -80.61 70.45 7.34 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.584 0.707 . . . . 0.0 109.571 176.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD12 ' HD2' ' A' ' 16' ' ' PRO . 20.3 tp -96.67 129.51 32.76 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.291 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.505 ' HD2' HD12 ' A' ' 15' ' ' LEU . 71.4 Cg_endo -76.82 4.84 5.33 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.702 2.268 . . . . 0.0 111.918 -177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 54.4 m -137.94 140.71 30.12 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 115.109 -0.951 . . . . 0.0 109.262 -174.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' THR . 28.9 Cg_endo -63.51 127.42 19.82 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.306 2.004 . . . . 0.0 111.982 179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 59.8 t -57.1 -25.31 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.922 0.391 . . . . 0.0 111.127 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -57.48 -21.64 38.82 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.907 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.7 t -82.07 -25.01 34.93 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 120.709 0.29 . . . . 0.0 111.0 -179.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 pt -102.09 179.97 0.62 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -161.53 175.64 11.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.64 0.257 . . . . 0.0 110.928 -175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.582 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 1.9 m-20 -62.12 -36.48 81.91 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.837 178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -79.19 -14.76 58.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.259 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -99.02 170.91 8.38 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.968 0.413 . . . . 0.0 111.464 -173.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' HA ' ' O ' ' A' ' 64' ' ' ALA . 7.3 m-20 -91.17 109.85 21.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.726 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 mp -64.22 -38.09 89.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.57 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -61.71 -24.66 66.92 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.408 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.7 -28.6 69.52 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.83 0.347 . . . . 0.0 111.118 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -74.34 -13.07 60.69 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 110.953 179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.99 42.99 1.71 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.046 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -59.23 109.51 0.88 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.951 0.405 . . . . 0.0 110.043 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.2 m -95.35 152.69 18.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.398 -177.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 39' ' ' VAL . 8.4 p -49.97 -48.45 52.19 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 123.538 0.524 . . . . 0.0 111.575 -177.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -58.04 -38.14 75.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.09 0.471 . . . . 0.0 110.87 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' HA ' ' H ' ' A' ' 14' ' ' GLN . . . -69.36 -44.24 71.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.083 -177.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.416 ' O ' ' HG3' ' A' ' 42' ' ' MET . 19.4 p -70.83 -37.56 73.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -176.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 35' ' ' SER . 97.7 t -67.29 -48.58 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.812 179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.535 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.8 tp60 -60.58 -32.43 71.52 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.187 0.518 . . . . 0.0 110.175 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.615 HD11 ' HE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -55.23 -38.67 68.77 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.179 174.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 38' ' ' SER . 39.6 mtt -68.36 -51.58 42.78 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.604 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.1 mp -56.16 -48.87 75.47 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.312 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.517 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -71.48 -31.79 65.34 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.638 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 8' ' ' ILE . 1.7 mm -76.32 -30.21 19.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 120.395 0.141 . . . . 0.0 111.15 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -56.83 -55.03 39.6 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.389 0.614 . . . . 0.0 110.128 176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -67.84 -29.12 68.19 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.864 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.04 -50.35 73.73 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -174.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -127.73 -33.46 2.27 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -178.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -179.0 -67.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.451 0.569 . . . . 0.0 112.074 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -135.17 167.97 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-O 120.746 0.308 . . . . 0.0 111.199 -176.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.97 168.65 9.06 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.89 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.619 ' HB3' HD11 ' A' ' 57' ' ' LEU . 59.3 m-85 -63.68 124.37 84.53 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.758 -174.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 154.69 53.66 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.821 2.347 . . . . 0.0 112.08 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.4 p-10 -58.18 -26.2 62.47 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.501 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.87 -49.2 59.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.308 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.619 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.8 pp -102.18 -5.59 24.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.282 -177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.539 ' HA ' ' CE1' ' A' ' 63' ' ' PHE . 3.5 tt -61.67 -46.43 89.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.064 0.459 . . . . 0.0 110.228 -178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -92.46 14.8 15.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.484 -178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 57' ' ' LEU . 10.7 tpt180 -100.13 168.42 9.83 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -172.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 62.8 pttt -66.31 -8.62 26.23 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.388 177.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.3 m -54.32 -34.93 62.06 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.855 -178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' CE1' ' HA ' ' A' ' 58' ' ' LEU . 26.0 m-85 -76.06 -4.71 42.86 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.565 ' O ' ' HA ' ' A' ' 27' ' ' ASP . . . -63.0 -48.09 80.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -141.74 136.88 31.21 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.263 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.582 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 30.1 mm -53.67 -48.56 59.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.265 -175.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.07 -27.73 14.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.608 0.242 . . . . 0.0 111.651 -172.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.99 -51.05 10.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.019 0.438 . . . . 0.0 110.825 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 14.8 tt -72.07 -33.82 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.789 -174.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HA ' HG12 ' A' ' 73' ' ' VAL . 1.2 pp20? -65.41 -31.9 73.25 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.728 0.299 . . . . 0.0 110.726 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -65.47 -41.41 93.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.145 0.497 . . . . 0.0 109.808 175.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 23.1 m -71.24 -39.65 71.53 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.267 -176.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.524 HG12 ' HA ' ' A' ' 70' ' ' GLU . 13.2 p -67.51 -29.31 45.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-O 120.756 0.312 . . . . 0.0 110.829 -178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 31.0 mtpp -64.48 -39.79 94.45 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.025 0.441 . . . . 0.0 110.182 174.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.25 -30.13 68.05 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.639 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 70.6 mt -62.06 -44.79 99.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.089 176.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.529 HD23 ' HD3' ' A' ' 80' ' ' LYS . 82.2 mt -69.37 -29.44 67.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.618 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -64.83 -35.3 80.68 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.6 176.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -140.27 71.25 0.43 Allowed Glycine 0 C--N 1.332 0.342 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.91 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.529 ' HD3' HD23 ' A' ' 77' ' ' LEU . 12.0 mmmm -59.88 -70.35 0.17 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.06 0.457 . . . . 0.0 111.239 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -92.51 34.86 1.04 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.315 -177.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -114.07 41.34 2.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.496 176.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.793 -177.574 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' HG13 ' A' ' 73' ' ' VAL . 46.7 ttm . . . . . 0 N--CA 1.485 1.289 0 CA-C-O 120.766 0.317 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -59.51 -47.28 86.15 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.004 -174.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.03 -34.98 76.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.12 0.486 . . . . 0.0 109.843 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.9 m -58.49 -41.87 86.29 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.351 -0.84 . . . . 0.0 110.69 176.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 8' ' ' ILE . 89.9 mt -58.79 -53.55 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.177 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -70.02 -26.8 64.22 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.917 0.389 . . . . 0.0 110.549 -178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -67.83 -37.99 82.64 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.169 -177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 5' ' ' ILE . 7.5 tt -62.46 -32.13 54.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 121.079 -0.248 . . . . 0.0 111.294 -176.003 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.38 -26.84 66.95 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.621 0.248 . . . . 0.0 111.257 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.05 -30.65 65.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.115 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.29 -62.36 1.39 Allowed 'General case' 0 CA--C 1.537 0.442 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.03 -175.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.605 ' HB2' HG12 ' A' ' 8' ' ' ILE . 38.7 m-85 -80.06 -36.32 35.8 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 122.194 -0.316 . . . . 0.0 111.403 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -63.16 102.49 0.53 Allowed Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.025 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -76.71 71.96 3.32 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.562 0.696 . . . . 0.0 109.968 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD12 ' HD2' ' A' ' 16' ' ' PRO . 17.0 tp -89.23 134.73 32.44 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.183 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.7 Cg_endo -75.12 -20.61 16.45 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.248 1.965 . . . . 0.0 111.055 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.0 m -109.08 139.33 20.86 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.674 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' O ' HG22 ' A' ' 21' ' ' THR . 18.9 Cg_endo -58.59 125.41 18.27 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.402 2.068 . . . . 0.0 112.157 -178.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.03 -24.55 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.063 -178.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -56.86 -25.24 56.16 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.747 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.522 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.2 t -79.66 -23.98 42.15 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.735 0.302 . . . . 0.0 111.095 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.461 HD12 HD22 ' A' ' 28' ' ' LEU . 25.9 pt -106.82 -178.52 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-O 120.727 0.299 . . . . 0.0 110.559 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -159.94 169.54 23.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.27 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.553 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 2.5 p30 -64.77 -17.17 63.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.65 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.586 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 47.8 mt-10 -104.29 4.54 33.8 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.047 177.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -111.87 164.69 12.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.031 0.444 . . . . 0.0 111.834 -173.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -70.22 91.98 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.76 178.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.473 HD11 HD11 ' A' ' 66' ' ' ILE . 76.8 mt -56.26 -45.65 79.98 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.129 0.49 . . . . 0.0 111.189 -179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.552 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 24.6 p90 -64.31 -21.47 66.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.017 -176.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -61.24 -32.84 72.64 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.985 0.422 . . . . 0.0 110.332 177.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -76.64 4.65 8.97 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.235 178.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.97 24.07 26.0 Favored Glycine 0 C--O 1.235 0.21 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.7 175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 51.9 tp -59.72 106.37 0.47 Allowed 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -101.93 161.06 13.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.884 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.1 t -48.28 -42.01 29.53 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 123.437 0.461 . . . . 0.0 111.627 -177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -56.01 -37.93 69.81 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.822 0.344 . . . . 0.0 111.226 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.8 -38.42 38.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.121 0.486 . . . . 0.0 110.399 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 42' ' ' MET . 18.1 m -66.02 -36.46 83.31 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.675 -177.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.68 -38.26 78.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.649 0.261 . . . . 0.0 110.782 -177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -64.76 -35.32 80.69 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.284 0.564 . . . . 0.0 109.738 177.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' O ' ' HB ' ' A' ' 45' ' ' ILE . 0.2 OUTLIER -55.22 -40.65 71.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.087 172.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 38' ' ' SER . 36.5 mtt -69.69 -56.53 6.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.952 -176.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -57.41 -48.06 80.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.287 -175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -67.04 -37.17 91.76 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.157 -177.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.5 mm -72.33 -33.43 45.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 120.439 0.161 . . . . 0.0 111.051 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.518 ' HG3' ' HA ' ' A' ' 51' ' ' ILE . 36.5 tt0 -58.44 -54.81 42.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.315 0.579 . . . . 0.0 109.948 177.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -69.49 -28.25 65.9 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.8 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.46 -50.72 72.7 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.544 ' CE2' HG23 ' A' ' 45' ' ' ILE . 39.0 p90 -128.35 -33.63 2.12 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -178.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD2' HG23 ' A' ' 51' ' ' ILE . 18.4 t70 -177.59 -70.44 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 118.844 0.747 . . . . 0.0 112.257 -176.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.573 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.66 174.61 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.844 0.354 . . . . 0.0 111.394 -175.689 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.44 168.63 9.18 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.51 176.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB3' HD11 ' A' ' 57' ' ' LEU . 27.3 m-85 -63.64 125.73 88.16 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.915 -173.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' HG ' ' A' ' 58' ' ' LEU . 73.1 Cg_endo -72.45 155.96 54.77 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.893 2.395 . . . . 0.0 112.744 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' HD12 ' A' ' 58' ' ' LEU . 2.9 m-20 -52.9 -32.6 46.1 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.507 -177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -57.23 -19.8 23.41 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.464 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.847 HD11 ' HB3' ' A' ' 53' ' ' PHE . 3.5 pp -127.53 -2.87 6.12 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 55' ' ' ASP . 79.4 mt -62.04 -33.51 74.51 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.999 0.428 . . . . 0.0 110.562 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.28 6.55 48.54 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.35 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -93.77 163.78 13.39 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.946 0.403 . . . . 0.0 110.797 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -68.38 -7.33 30.47 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.307 178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.6 m -42.23 -37.27 1.43 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.662 0.785 . . . . 0.0 112.892 -177.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -67.75 -32.97 73.94 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 120.71 0.291 . . . . 0.0 111.619 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HB2' ' HE2' ' A' ' 29' ' ' TYR . . . -72.38 -19.63 61.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.198 0.523 . . . . 0.0 110.64 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.621 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 49.5 m -126.94 81.74 2.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.957 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.595 ' HA ' HG22 ' A' ' 69' ' ' ILE . 55.1 mt -57.46 -36.11 52.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.17 -175.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.621 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.3 OUTLIER -58.48 -28.89 65.77 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.015 177.571 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.69 -46.17 14.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.031 0.443 . . . . 0.0 110.695 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.595 HG22 ' HA ' ' A' ' 66' ' ' ILE . 13.5 tt -66.06 -32.11 56.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.066 -176.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HA ' HG12 ' A' ' 73' ' ' VAL . 0.1 OUTLIER -62.89 -41.64 99.5 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.894 0.378 . . . . 0.0 110.168 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.536 ' O ' ' HG ' ' A' ' 75' ' ' LEU . 29.6 t70 -65.47 -35.08 79.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.25 0.548 . . . . 0.0 109.656 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 20.0 m -70.29 -41.68 73.06 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.201 -178.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.527 HG13 ' SD ' ' A' ' 1' ' ' MET . 13.0 p -71.53 -30.73 40.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.954 0.407 . . . . 0.0 110.233 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.402 ' HD3' ' O ' ' A' ' 70' ' ' GLU . 33.4 mtpt -60.59 -34.35 74.07 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.272 173.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 71' ' ' ASP . 84.6 mt -65.75 -33.98 77.13 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.339 176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.505 HD12 HG23 ' A' ' 73' ' ' VAL . 68.3 mt -61.35 -52.92 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 176.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -58.61 -30.73 67.47 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.77 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.54 -29.29 67.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.404 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.88 68.05 0.4 Allowed Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.507 -177.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -81.96 -45.37 15.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.193 0.521 . . . . 0.0 110.628 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 73.34 21.98 2.88 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.57 -175.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.6 80.44 3.27 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.828 177.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.516 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' CE1' ' A' ' 49' ' ' PHE . 52.5 ttp . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 120.434 0.159 . . . . 0.0 111.178 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -61.5 -46.24 90.84 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.781 0.324 . . . . 0.0 111.404 -176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -77.06 -31.53 56.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.995 0.426 . . . . 0.0 110.224 -179.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.0 m -52.48 -38.55 59.69 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.316 -0.857 . . . . 0.0 110.948 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.598 ' O ' HG22 ' A' ' 8' ' ' ILE . 87.8 mt -55.38 -60.15 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.879 -178.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -74.53 -23.26 58.78 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.845 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -59.72 -41.24 90.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.983 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 5' ' ' ILE . 8.0 tt -62.11 -31.69 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.131 -175.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 4.3 mm? -54.92 -25.96 32.8 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.701 0.286 . . . . 0.0 111.185 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -75.57 -29.83 59.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.553 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' HG3' ' HD1' ' A' ' 12' ' ' PHE . 17.1 ptmt -106.83 -52.06 2.83 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.598 ' HB2' HG12 ' A' ' 8' ' ' ILE . 57.1 m-85 -99.52 -15.11 18.77 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 120.638 0.256 . . . . 0.0 111.393 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' A' ' 9' ' ' LEU . . . -67.54 117.02 8.4 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.429 -178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.488 HE21 ' HG2' ' A' ' 40' ' ' GLN . 73.3 mm-40 -82.07 47.2 1.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.162 0.506 . . . . 0.0 110.285 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 16' ' ' PRO . 21.7 tp -86.62 129.11 54.1 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.536 -179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 15' ' ' LEU . 57.4 Cg_endo -73.78 -16.85 23.33 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.162 1.908 . . . . 0.0 111.253 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.512 HG23 ' HD2' ' A' ' 18' ' ' PRO . 36.1 m -109.09 142.32 25.3 Favored Pre-proline 0 N--CA 1.442 -0.828 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.725 -175.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.512 ' HD2' HG23 ' A' ' 17' ' ' THR . 18.9 Cg_endo -59.67 128.53 27.34 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.529 2.153 . . . . 0.0 112.384 -177.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.9 t -60.98 -19.65 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.126 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -57.72 -30.22 65.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.56 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.499 HG22 ' O ' ' A' ' 18' ' ' PRO . 4.1 t -75.63 -26.09 57.44 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.794 0.33 . . . . 0.0 110.994 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.402 HD12 ' HG ' ' A' ' 28' ' ' LEU . 25.6 pt -100.45 170.54 1.5 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.301 -179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' N ' ' HB3' ' A' ' 26' ' ' ALA . . . -166.59 -175.57 3.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.631 -174.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.535 ' HA ' ' HB ' ' A' ' 66' ' ' ILE . 9.5 m-20 -54.86 -43.49 73.14 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.801 -177.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -104.26 3.47 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.685 -176.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 28' ' ' LEU . . . -98.89 119.95 38.52 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 30' ' ' ALA . 14.9 p-10 -56.17 102.04 0.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.46 0.648 . . . . 0.0 111.679 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD12 ' O ' ' A' ' 26' ' ' ALA . 6.7 mp -58.51 -40.88 84.07 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.014 -173.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.475 ' HA ' ' HB3' ' A' ' 33' ' ' LEU . 44.5 p90 -58.29 -27.55 64.18 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.724 -175.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . . . -61.23 -31.88 71.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.899 0.381 . . . . 0.0 111.159 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -70.4 -15.77 62.88 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.869 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 107.52 46.02 1.09 Allowed Glycine 0 N--CA 1.452 -0.236 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.65 -178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' A' ' 29' ' ' TYR . 58.5 tp -69.0 112.8 5.86 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 110.138 179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 31.4 t -94.9 153.5 17.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.49 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.9 p -59.97 -31.22 69.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.361 176.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -67.5 -28.88 68.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.237 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.42 -40.44 35.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.409 178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 41' ' ' LEU . 15.2 p -68.57 -39.71 80.87 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.526 -177.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HD23 ' A' ' 43' ' ' LEU . 9.7 p -66.84 -45.42 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.548 ' HG3' ' HB3' ' A' ' 12' ' ' PHE . 6.6 tp-100 -63.43 -33.55 75.8 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 177.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -60.59 -51.77 68.0 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.479 176.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.556 ' O ' ' HB3' ' A' ' 52' ' ' GLU . 26.2 ptm -69.83 -38.45 76.55 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.855 -176.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 39' ' ' VAL . 4.1 mm? -62.07 -45.5 93.28 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.618 0.247 . . . . 0.0 110.886 179.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.437 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -72.8 -33.24 60.4 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.069 178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.519 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.8 OUTLIER -68.43 -27.78 37.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-O 120.657 0.265 . . . . 0.0 110.719 178.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -55.08 -55.47 30.62 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.525 177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -72.18 -29.9 64.44 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.727 0.299 . . . . 0.0 110.81 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.83 -49.85 64.9 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.448 -174.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.519 ' CE2' HG23 ' A' ' 45' ' ' ILE . 54.8 p90 -129.38 -34.0 1.86 Allowed 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD1' HG23 ' A' ' 51' ' ' ILE . 9.4 t70 -177.1 -65.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.696 0.68 . . . . 0.0 112.386 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -138.17 176.39 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-O 120.928 0.394 . . . . 0.0 111.183 -178.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.556 ' HB3' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -105.44 168.01 9.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.726 175.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.795 ' HB3' HD11 ' A' ' 57' ' ' LEU . 38.4 m-85 -67.79 130.33 92.98 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.681 -172.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.441 ' HD2' HD21 ' A' ' 57' ' ' LEU . 91.8 Cg_endo -79.91 157.92 24.13 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.122 2.548 . . . . 0.0 112.52 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -55.11 -33.8 63.14 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.052 -174.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -56.82 -23.72 45.75 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -175.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.795 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.4 pp -121.43 -2.44 9.49 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -177.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 54' ' ' PRO . 73.2 mt -62.27 -58.59 7.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.141 -177.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -81.56 69.2 8.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.837 0.351 . . . . 0.0 110.284 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' LEU . 75.6 mtt180 -150.04 -175.36 5.02 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.427 -179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -70.18 -6.77 36.71 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.863 176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 34.7 p -40.56 -63.16 0.67 Allowed 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.595 0.758 . . . . 0.0 112.435 -176.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -70.62 -10.01 58.31 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.735 -177.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -94.42 -13.33 26.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.475 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 50.1 m -147.04 99.24 3.15 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.372 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.535 ' HB ' ' HA ' ' A' ' 24' ' ' ASP . 49.9 mm -59.32 -42.86 88.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.356 -175.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.475 ' HE3' ' HB3' ' A' ' 65' ' ' SER . 0.4 OUTLIER -57.55 -26.79 61.93 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.378 179.853 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.12 -52.16 7.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.704 0.288 . . . . 0.0 110.803 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG22 ' HA ' ' A' ' 66' ' ' ILE . 15.5 tt -63.37 -32.88 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.501 -175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -62.76 -29.54 70.77 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.782 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -74.73 -51.15 15.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.94 0.4 . . . . 0.0 110.821 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -60.45 -37.97 82.66 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.637 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.85 -29.75 47.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-O 120.653 0.263 . . . . 0.0 111.079 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 94.8 mttt -62.51 -32.92 73.93 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.821 0.343 . . . . 0.0 110.715 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 87.4 mt -59.8 -30.58 69.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 59.5 mt -66.32 -53.14 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.791 177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.78 -29.54 70.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.692 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.05 -27.74 69.31 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.25 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -155.51 62.21 0.35 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.72 -178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 41.7 mtmt -64.99 -71.54 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.953 0.406 . . . . 0.0 110.601 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 59.73 16.57 5.63 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.479 -175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.19 103.55 14.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.558 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.553 -0.737 . . . . 0.0 110.325 -179.211 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 5' ' ' ILE . 32.2 ttm . . . . . 0 N--CA 1.481 1.115 0 CA-C-O 120.485 0.183 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -57.47 -46.96 83.08 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.632 -0.258 . . . . 0.0 111.568 -174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -78.22 -32.23 49.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.095 0.474 . . . . 0.0 109.789 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.5 m -52.46 -40.14 61.92 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.916 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.636 ' O ' HG22 ' A' ' 8' ' ' ILE . 81.4 mt -53.32 -59.84 1.59 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.145 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.15 -25.38 62.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.865 0.364 . . . . 0.0 110.426 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -63.65 -42.31 98.12 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.791 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 5' ' ' ILE . 9.0 tt -64.0 -32.84 58.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.105 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 41' ' ' LEU . 4.2 mm? -57.33 -29.28 63.84 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.79 -30.3 61.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.826 0.346 . . . . 0.0 111.661 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -110.75 -15.57 13.79 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -172.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.558 ' HB2' HG12 ' A' ' 8' ' ' ILE . 45.7 m-85 -128.73 -36.1 1.85 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.89 124.27 28.24 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.738 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -77.41 64.03 2.7 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.311 0.577 . . . . 0.0 110.694 178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.58 HD12 ' HD2' ' A' ' 16' ' ' PRO . 23.9 tp -93.98 130.78 33.44 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.586 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.58 ' HD2' HD12 ' A' ' 15' ' ' LEU . 59.3 Cg_endo -74.76 -13.78 21.92 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.376 2.051 . . . . 0.0 111.245 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.445 ' H ' ' HG ' ' A' ' 15' ' ' LEU . 7.1 m -110.36 141.46 23.99 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.573 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.577 ' O ' HG22 ' A' ' 21' ' ' THR . 29.3 Cg_endo -64.13 122.16 10.06 Favored 'Trans proline' 0 CA--C 1.533 0.463 0 C-N-CA 122.12 1.88 . . . . 0.0 111.557 178.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.448 ' HA ' HG12 ' A' ' 22' ' ' ILE . 69.2 t -58.69 -20.02 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.951 -178.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -56.58 -27.63 58.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.651 177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 18' ' ' PRO . 5.9 t -87.99 -23.33 23.86 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -175.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.566 HD12 ' HG ' ' A' ' 28' ' ' LEU . 34.7 pt -96.55 174.11 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.883 0.373 . . . . 0.0 110.658 -179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.552 ' H ' ' HB3' ' A' ' 26' ' ' ALA . . . -155.78 -173.36 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.331 -176.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.424 ' HB2' ' HB ' ' A' ' 66' ' ' ILE . 7.8 p-10 -70.33 -30.38 67.33 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -171.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.543 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 26.3 mt-10 -98.81 1.62 46.05 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.876 0.37 . . . . 0.0 111.038 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.552 ' HB3' ' H ' ' A' ' 23' ' ' ALA . . . -85.19 154.98 21.63 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.017 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -83.11 92.3 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.566 ' HG ' HD12 ' A' ' 22' ' ' ILE . 7.5 mp -54.19 -42.03 69.23 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.003 -177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -62.46 -31.52 72.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.142 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.8 -27.69 65.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.985 0.421 . . . . 0.0 110.355 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -71.71 -19.74 62.02 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.417 0.627 . . . . 0.0 109.979 174.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.84 27.81 2.43 Favored Glycine 0 C--O 1.236 0.251 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.607 174.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.459 HD21 ' HB3' ' A' ' 38' ' ' SER . 7.8 tt -81.71 115.2 20.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.7 t -104.59 174.18 5.99 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.441 ' O ' HG13 ' A' ' 39' ' ' VAL . 15.4 m -58.76 -28.22 65.71 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.614 -174.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -66.47 -41.37 89.12 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.633 0.254 . . . . 0.0 110.952 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.07 -33.63 73.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.825 0.345 . . . . 0.0 110.69 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.782 ' HA ' HD23 ' A' ' 41' ' ' LEU . 40.8 p -75.22 -46.6 32.88 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.233 -178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG13 ' O ' ' A' ' 35' ' ' SER . 34.6 m -63.33 -32.39 56.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.815 0.341 . . . . 0.0 110.695 -178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -66.99 -37.35 84.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.189 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.782 HD23 ' HA ' ' A' ' 38' ' ' SER . 0.3 OUTLIER -68.78 -25.54 64.75 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.108 -177.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.564 ' SD ' HD21 ' A' ' 58' ' ' LEU . 37.3 mtm -66.71 -56.02 12.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.873 -176.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.546 HD12 ' N ' ' A' ' 44' ' ' GLY . 4.2 pp -61.57 -31.83 71.9 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.3 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HD11 ' A' ' 8' ' ' ILE . . . -74.97 -40.2 36.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.384 177.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.435 HG23 ' CE2' ' A' ' 49' ' ' PHE . 1.2 mm -69.53 -27.88 35.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 120.707 0.289 . . . . 0.0 110.714 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.01 -55.38 35.45 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.214 0.53 . . . . 0.0 110.28 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -71.22 -29.13 64.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.87 -50.28 66.64 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 45' ' ' ILE . 48.1 p90 -128.88 -33.33 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' OD2' HG23 ' A' ' 51' ' ' ILE . 38.7 t70 -178.96 -66.73 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 118.154 0.434 . . . . 0.0 111.575 -177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 51' ' ' ILE . 0.2 OUTLIER -136.01 177.62 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 121.081 0.467 . . . . 0.0 111.202 -179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 169.61 8.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.841 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.604 ' HB3' HD11 ' A' ' 57' ' ' LEU . 39.5 m-85 -62.44 117.55 32.02 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.449 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.422 ' HD2' HD21 ' A' ' 57' ' ' LEU . 59.7 Cg_endo -68.99 152.61 73.23 Favored 'Trans proline' 0 C--O 1.238 0.486 0 C-N-CA 122.887 2.391 . . . . 0.0 112.185 -177.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 6.7 p-10 -55.27 -25.5 34.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.382 -177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -62.01 -34.97 77.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.724 -177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.604 HD11 ' HB3' ' A' ' 53' ' ' PHE . 4.3 pp -109.69 -2.06 17.67 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 120.76 0.314 . . . . 0.0 110.772 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.564 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.3 OUTLIER -63.91 89.73 0.05 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 47.7 t-20 -153.85 152.21 30.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.399 -176.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.434 ' N ' ' OD1' ' A' ' 59' ' ' ASN . 19.5 mmt180 -47.46 -41.5 20.63 Favored 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.532 0.52 . . . . 0.0 110.957 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -53.3 -49.66 66.52 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.725 -175.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.7 m -62.42 -47.0 86.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.157 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -74.73 -17.44 60.65 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.208 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -78.0 -11.87 59.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.241 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' HE3' ' A' ' 67' ' ' LYS . 40.4 m -146.46 91.44 2.04 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.928 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.577 ' HA ' HG22 ' A' ' 69' ' ' ILE . 48.7 mm -58.22 -42.79 84.34 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.095 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.543 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -55.25 -27.93 49.81 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.732 0.301 . . . . 0.0 111.569 179.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -81.98 -44.35 16.82 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.187 0.518 . . . . 0.0 110.981 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG22 ' HA ' ' A' ' 66' ' ' ILE . 14.1 tt -72.34 -32.59 42.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.256 -175.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 0.7 OUTLIER -63.07 -30.38 71.55 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.919 0.39 . . . . 0.0 110.523 -178.115 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.09 -43.45 43.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.321 0.581 . . . . 0.0 110.354 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 29.4 m -64.47 -31.57 72.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.536 -175.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.405 HG13 ' SD ' ' A' ' 1' ' ' MET . 14.2 p -72.21 -29.64 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 120.971 0.415 . . . . 0.0 110.151 178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 70' ' ' GLU . 93.1 mttt -66.49 -28.48 68.61 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.147 177.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -61.45 -30.7 70.76 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.197 175.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.526 HG21 HG13 ' A' ' 51' ' ' ILE . 56.2 mt -66.3 -46.37 87.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HA ' ' HG2' ' A' ' 80' ' ' LYS . 3.8 mm? -62.61 -31.45 72.29 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.038 177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -69.71 -30.84 68.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.36 176.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.48 28.66 11.98 Favored Glycine 0 CA--C 1.521 0.452 0 CA-C-N 116.112 -0.494 . . . . 0.0 113.304 -177.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.48 ' HG2' ' HA ' ' A' ' 77' ' ' LEU . 28.8 mmmt -74.42 -66.81 0.69 Allowed 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 175.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 56.46 81.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.282 178.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -140.76 97.32 3.17 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.97 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.495 -177.897 . . . . . . . . 0 0 . 1 stop_ save_